
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE530F1A8AEED833050F1A000A62B716.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jvim">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Veterinary Internal Medicine">
<meta name="citation_title" content="Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series">
<meta name="citation_author" content="Linda Toresson">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_author_institution" content="Evidensia Specialist Animal Hospital, Helsingborg, Sweden">
<meta name="citation_author" content="Amanda B Blake">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_author" content="Chi‐Hsuan Sung">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_author" content="Gunilla Olmedal">
<meta name="citation_author_institution" content="Evidensia Specialist Animal Hospital, Helsingborg, Sweden">
<meta name="citation_author" content="Ulrika Ludvigsson">
<meta name="citation_author_institution" content="Evidensia Specialist Animal Hospital, Helsingborg, Sweden">
<meta name="citation_author" content="Paula R Giaretta">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_author" content="M Katherine Tolbert">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_author" content="Jan S Suchodolski">
<meta name="citation_author_institution" content="Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="39">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70206">
<meta name="citation_doi" content="10.1111/jvim.70206">
<meta name="citation_pmid" content="40833185">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/pdf/JVIM-39-e70206.pdf">
<meta name="description" content="Bile acid (BA) malabsorption and BA diarrhea (BAD) are prevalent but underdiagnosed conditions in people with chronic diarrhea of multiple causes. Recent studies have shown BA dysmetabolism in dogs with chronic enteropathies (CE). Describe canine ...">
<meta name="og:title" content="Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Bile acid (BA) malabsorption and BA diarrhea (BAD) are prevalent but underdiagnosed conditions in people with chronic diarrhea of multiple causes. Recent studies have shown BA dysmetabolism in dogs with chronic enteropathies (CE). Describe canine ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365994">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/jvim.70206"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/JVIM-39-e70206.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365994%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365994/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365994/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jvim.gif" alt="Journal of Veterinary Internal Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Veterinary Internal Medicine" title="Link to Journal of Veterinary Internal Medicine" shape="default" href="http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1939-1676" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Vet Intern Med</button></div>. 2025 Aug 20;39(5):e70206. doi: <a href="https://doi.org/10.1111/jvim.70206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/jvim.70206</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Vet%20Intern%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Vet%20Intern%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Vet%20Intern%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Vet%20Intern%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toresson%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Linda Toresson</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Linda Toresson</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Evidensia Specialist Animal Hospital, Helsingborg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toresson%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Linda Toresson</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blake%20AB%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Amanda B Blake</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Amanda B Blake</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blake%20AB%22%5BAuthor%5D" class="usa-link"><span class="name western">Amanda B Blake</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sung%20CH%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chi‐Hsuan Sung</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chi‐Hsuan Sung</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sung%20CH%22%5BAuthor%5D" class="usa-link"><span class="name western">Chi‐Hsuan Sung</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olmedal%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Gunilla Olmedal</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Gunilla Olmedal</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Evidensia Specialist Animal Hospital, Helsingborg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olmedal%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gunilla Olmedal</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ludvigsson%20U%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ulrika Ludvigsson</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ulrika Ludvigsson</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Evidensia Specialist Animal Hospital, Helsingborg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ludvigsson%20U%22%5BAuthor%5D" class="usa-link"><span class="name western">Ulrika Ludvigsson</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giaretta%20PR%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Paula R Giaretta</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Paula R Giaretta</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giaretta%20PR%22%5BAuthor%5D" class="usa-link"><span class="name western">Paula R Giaretta</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tolbert%20MK%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">M Katherine Tolbert</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">M Katherine Tolbert</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tolbert%20MK%22%5BAuthor%5D" class="usa-link"><span class="name western">M Katherine Tolbert</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suchodolski%20JS%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jan S Suchodolski</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jan S Suchodolski</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suchodolski%20JS%22%5BAuthor%5D" class="usa-link"><span class="name western">Jan S Suchodolski</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="jvim70206-aff-0001">
<sup>
<sup>1</sup>
</sup>Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&amp;M University, College Station, Texas, USA</div>
<div id="jvim70206-aff-0002">
<sup>
<sup>2</sup>
</sup>Evidensia Specialist Animal Hospital, Helsingborg, Sweden</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Linda Toresson (<span>ltor@tamu.edu</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 28; Received 2025 Feb 6; Accepted 2025 Jul 29; Collection date 2025 Sep-Oct.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Journal of Veterinary Internal Medicine</em> published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365994  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40833185/" class="usa-link">40833185</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="jvim70206-sec-0001"><h3 class="pmc_sec_title">Background</h3>
<p>Bile acid (BA) malabsorption and BA diarrhea (BAD) are prevalent but underdiagnosed conditions in people with chronic diarrhea of multiple causes. Recent studies have shown BA dysmetabolism in dogs with chronic enteropathies (CE).</p></section><section id="jvim70206-sec-0002"><h3 class="pmc_sec_title">Objective</h3>
<p>Describe canine inflammatory bowel disease activity index (CIBDAI), dysbiosis index (DI) and fecal BA concentrations in healthy dogs and dogs with refractory or partially immunosuppressive‐responsive CE or CE dogs requiring high doses of corticosteroids, treated with BA sequestrants (BAS).</p></section><section id="jvim70206-sec-0003"><h3 class="pmc_sec_title">Animals</h3>
<p>Twenty‐four CE dogs and 18 healthy dogs.</p></section><section id="jvim70206-sec-0004"><h3 class="pmc_sec_title">Methods</h3>
<p>Retrospective case series. Dogs with CE were treated with BAS as adjunctive treatment. Fecal BA was analyzed using liquid chromatography–tandem mass spectrometry. Fecal microbiota was assessed using DI. Response to treatment was defined as a decrease in CIBDAI category.</p></section><section id="jvim70206-sec-0005"><h3 class="pmc_sec_title">Results</h3>
<p>Sixteen of 24 dogs improved clinically after BAS treatment (cholestyramine, 44–133 mg/kg q12h; colesevelam, 7–24 mg/kg q12h; colestipole, 26 mg/kg q24h). Duration of treatment was 5–47 months. Median (range) CIBDAI decreased from 6.5 (4–13) to 3 (2–5) in responders. At baseline, responders had a higher median (range) percentage of fecal unconjugated primary BAs (93 [1–100]) versus non‐responders (2.5 [0–95]) and healthy dogs (1.5 [0–19]). Dysbiosis index (median [range]) was higher in responders (4.2 [−4.7 to 9.0]) versus non‐responders (−0.1 [−1.5 to 5.7]) and healthy dogs (−4.5 [−6.4 to −0.2]).</p></section><section id="jvim70206-sec-0006"><h3 class="pmc_sec_title">Conclusions and Clinical Importance</h3>
<p>Treatment with BAS as adjunctive treatment potentially may benefit some dogs with nonresponsive or partially immunosuppressive‐responsive enteropathy or CE dogs requiring high doses of corticosteroids.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> bile acid diarrhea, bile acid dysmetabolism, cholestyramine, colesevelam, non‐responsive enteropathy</p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="jvim70206-dl-0001">
<dt id="jvim70206-li-0001">ASBT</dt>
<dd id="jvim70206-li-0002"><p>apical sodium‐dependent bile acid transporter</p></dd>
<dt id="jvim70206-li-0003">BA</dt>
<dd id="jvim70206-li-0004"><p>bile acids</p></dd>
<dt id="jvim70206-li-0005">BAD</dt>
<dd id="jvim70206-li-0006"><p>bile acid diarrhea</p></dd>
<dt id="jvim70206-li-0007">BAM</dt>
<dd id="jvim70206-li-0008"><p>bile acid malabsorption</p></dd>
<dt id="jvim70206-li-0009">BAS</dt>
<dd id="jvim70206-li-0010"><p>bile acid sequestrants</p></dd>
<dt id="jvim70206-li-0011">CE</dt>
<dd id="jvim70206-li-0012"><p>chronic enteropathy</p></dd>
<dt id="jvim70206-li-0013">CE+BASR</dt>
<dd id="jvim70206-li-0014"><p>chronic enteropathy responding to bile acid sequestrants</p></dd>
<dt id="jvim70206-li-0015">CE−BASR</dt>
<dd id="jvim70206-li-0016"><p>chronic enteropathy non‐responsive to bile acid sequestrants</p></dd>
<dt id="jvim70206-li-0017">CI</dt>
<dd id="jvim70206-li-0018"><p>confidence interval</p></dd>
<dt id="jvim70206-li-0019">CIBDAI</dt>
<dd id="jvim70206-li-0020"><p>canine inflammatory bowel disease activity index</p></dd>
<dt id="jvim70206-li-0021">DI</dt>
<dd id="jvim70206-li-0022"><p>dysbiosis index</p></dd>
<dt id="jvim70206-li-0023">ESAHHS</dt>
<dd id="jvim70206-li-0024"><p>Evidensia Specialist Animal Hospital, Helsingborg, Sweden</p></dd>
<dt id="jvim70206-li-0025">f1BA</dt>
<dd id="jvim70206-li-0026"><p>fecal primary bile acids</p></dd>
<dt id="jvim70206-li-0027">f2BA</dt>
<dd id="jvim70206-li-0028"><p>fecal secondary bile acids</p></dd>
<dt id="jvim70206-li-0029">fBA</dt>
<dd id="jvim70206-li-0030"><p>fecal bile acids</p></dd>
<dt id="jvim70206-li-0031">FMT</dt>
<dd id="jvim70206-li-0032"><p>fecal microbiota transplantation</p></dd>
<dt id="jvim70206-li-0033">HSDH</dt>
<dd id="jvim70206-li-0034"><p>hydroxysteroid dehydrogenase</p></dd>
<dt id="jvim70206-li-0035">IBS‐D</dt>
<dd id="jvim70206-li-0036"><p>irritable bowel syndrome with diarrhea</p></dd>
<dt id="jvim70206-li-0037">IRE</dt>
<dd id="jvim70206-li-0038"><p>immunosuppressive‐responsive enteropathy</p></dd>
<dt id="jvim70206-li-0039">NRE</dt>
<dd id="jvim70206-li-0040"><p>non‐responsive enteropathy</p></dd>
<dt id="jvim70206-li-0041">P‐IRE</dt>
<dd id="jvim70206-li-0042"><p>partially immunosuppressive‐responsive enteropathy</p></dd>
<dt id="jvim70206-li-0043">PLE</dt>
<dd id="jvim70206-li-0044"><p>protein‐losing enteropathy</p></dd>
<dt id="jvim70206-li-0045">RI</dt>
<dd id="jvim70206-li-0046"><p>reference interval</p></dd>
</dl>
<section id="jvim70206-sec-0007"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Primary bile acids (1BA) are detergent molecules that are synthesized in the liver, conjugated to glycine or taurine, stored in the gallbladder, and released into the duodenum to facilitate fat digestion. Approximately 95% of 1BA are reabsorbed in the ileum by the apical sodium‐dependent BA transporter (ASBT) and undergo enterohepatic circulation [<a href="#jvim70206-bib-0001" class="usa-link" aria-describedby="jvim70206-bib-0001">1</a>]. Unabsorbed 1BA are deconjugated to cholic acid and chenodeoxycholic acid and dehydroxylated by 7α‐dehydroxylating colonic bacteria (mainly <em>Peptacetobacter</em> [previously <em>Clostridium</em>] <em>hiranonis</em> in dogs) to the secondary BAs (2BA), deoxycholic acid and lithocholic acid [<a href="#jvim70206-bib-0002" class="usa-link" aria-describedby="jvim70206-bib-0002">2</a>, <a href="#jvim70206-bib-0003" class="usa-link" aria-describedby="jvim70206-bib-0003">3</a>, <a href="#jvim70206-bib-0004" class="usa-link" aria-describedby="jvim70206-bib-0004">4</a>]. In healthy dogs and people, the majority of fecal BA are 2BA [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0006" class="usa-link" aria-describedby="jvim70206-bib-0006">6</a>, <a href="#jvim70206-bib-0007" class="usa-link" aria-describedby="jvim70206-bib-0007">7</a>].</p>
<p>Decreased absorptive capacity of the ileum, accelerated transit time, and overproduction of BAs can result in BA malabsorption (BAM) and BA diarrhea (BAD) [<a href="#jvim70206-bib-0008" class="usa-link" aria-describedby="jvim70206-bib-0008">8</a>, <a href="#jvim70206-bib-0009" class="usa-link" aria-describedby="jvim70206-bib-0009">9</a>, <a href="#jvim70206-bib-0010" class="usa-link" aria-describedby="jvim70206-bib-0010">10</a>]. Furthermore, intestinal dysbiosis with a lack of 7α‐dehydroxylating colonic bacteria leads to decreased conversion to 2BAs and can generate BAD [<a href="#jvim70206-bib-0007" class="usa-link" aria-describedby="jvim70206-bib-0007">7</a>]. Despite a high prevalence of BAD in patients with Crohn's disease and diarrhea‐associated irritable bowel syndrome, BAD is an underrecognized and undertreated condition [<a href="#jvim70206-bib-0011" class="usa-link" aria-describedby="jvim70206-bib-0011">11</a>, <a href="#jvim70206-bib-0012" class="usa-link" aria-describedby="jvim70206-bib-0012">12</a>], mainly because of a lack of diagnostic tools. Consequently, clinical response to empirically‐administered BA sequestrants (BAS) often is used to diagnose BAD in people.</p>
<p>Recent studies suggest that BA dysmetabolism occurs also in dogs. In a preliminary study, serum concentrations of 7α‐hydroxy‐4‐cholesten‐3‐one (C4), a metabolite of BA synthesis, were significantly increased in 3/17 dogs with refractory chronic diarrhea [<a href="#jvim70206-bib-0013" class="usa-link" aria-describedby="jvim70206-bib-0013">13</a>]. Supranormal serum C4 concentrations are indicative of BAM in people [<a href="#jvim70206-bib-0014" class="usa-link" aria-describedby="jvim70206-bib-0014">14</a>, <a href="#jvim70206-bib-0015" class="usa-link" aria-describedby="jvim70206-bib-0015">15</a>]. Furthermore, BA dysmetabolism or decreased expression of ASBT in the ileum of dogs with chronic enteropathy (CE) has been reported [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0006" class="usa-link" aria-describedby="jvim70206-bib-0006">6</a>, <a href="#jvim70206-bib-0007" class="usa-link" aria-describedby="jvim70206-bib-0007">7</a>, <a href="#jvim70206-bib-0016" class="usa-link" aria-describedby="jvim70206-bib-0016">16</a>, <a href="#jvim70206-bib-0017" class="usa-link" aria-describedby="jvim70206-bib-0017">17</a>]. A subset of dogs with CE had significantly lower amounts of fecal 2BA (f2BA) and increased percentage and amount of fecal 1BA (f1BA) compared to healthy dogs. The percentage of f2BA significantly increased over time in CE dogs responding to diet or corticosteroids [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0017" class="usa-link" aria-describedby="jvim70206-bib-0017">17</a>]. Intestinal dysbiosis has been reported in parallel with BA dysmetabolism in dogs with CE, typically characterized by increased dysbiosis index (DI) [<a href="#jvim70206-bib-0018" class="usa-link" aria-describedby="jvim70206-bib-0018">18</a>] and decreased abundance of the bile acid‐converting bacterium <em>P. hiranonis</em> [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0006" class="usa-link" aria-describedby="jvim70206-bib-0006">6</a>, <a href="#jvim70206-bib-0016" class="usa-link" aria-describedby="jvim70206-bib-0016">16</a>]. Only one case report is available on treatment of suspected BAD in dogs [<a href="#jvim70206-bib-0019" class="usa-link" aria-describedby="jvim70206-bib-0019">19</a>]. Two dogs with chronic refractory diarrhea responded to cholestyramine, a BAS. The positive clinical effect in these dogs has led us to prescribe BAS to some dogs with CE when traditionally used treatment protocols have failed, or when high corticosteroid doses associated with marked adverse effects were required to control disease [<a href="#jvim70206-bib-0020" class="usa-link" aria-describedby="jvim70206-bib-0020">20</a>, <a href="#jvim70206-bib-0021" class="usa-link" aria-describedby="jvim70206-bib-0021">21</a>]. The aim of our retrospective study was to describe clinical features and fecal variables in healthy dogs, non‐ or partially‐responsive CE dogs, and CE dogs requiring high doses of corticosteroids, responding to versus not responding to BAS.</p></section><section id="jvim70206-sec-0008"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="jvim70206-sec-0009"><h3 class="pmc_sec_title">2.1. Study Design and Ethics Approval</h3>
<p>Ours was a retrospective study based on a review of medical records at the Evidensia Specialist Animal Hospital in Helsingborg, Sweden (ESAHHS) from November 2019 to March 2025. Naturally voided baseline fecal samples from CE dogs were stored at −20°C. In Sweden, formal ethical approval is not required for storing and using naturally‐ voided fecal samples from dogs for research purposes. However, 8/24 dogs were included in a prospective study on fecal microbiota transplantation (FMT). These dogs responded poorly to FMT and subsequently were started on BAS, according to the study protocol. The FMT study was approved by the animal ethics committee of Uppsala University, Uppsala, Sweden (5.8.18–138 777/2021; approved 24 September 2021).</p>
<p>A decrease of CIBDAI category after treatment (i.e., from severe or moderate to mild or insignificant and from mild to insignificant) was regarded as a response to BAS. This approach is similar to the one used in a study on corticosteroid‐refractory CE dogs treated with cyclosporine [<a href="#jvim70206-bib-0022" class="usa-link" aria-describedby="jvim70206-bib-0022">22</a>]. Canine inflammatory bowel disease index (CIBDAI) [<a href="#jvim70206-bib-0023" class="usa-link" aria-describedby="jvim70206-bib-0023">23</a>], fecal bile acids (fBA), DI, and abundance of <em>P. hiranonis</em> based on qPCR analysis [<a href="#jvim70206-bib-0018" class="usa-link" aria-describedby="jvim70206-bib-0018">18</a>] were compared between BAS responders and non‐responders. For comparison, data from 18 healthy staff‐owned dogs from ESAHHS were included after informed owner consent.</p></section><section id="jvim70206-sec-0010"><h3 class="pmc_sec_title">2.2. Study Population, Treatment and CIBDAI
</h3>
<p>Inclusion criteria were privately‐owned dogs with chronic diarrhea treated with BAS (cholestyramine, colesevelam, or colestipol) at the ESAHHS, with a baseline fecal sample collected before intervention. Previous diagnostic testing included serum biochemistry and hematology, basal cortisol concentration, serum canine pancreatic lipase, cobalamin and folate concentrations, abdominal ultrasound imaging, fecal flotation, and Giardia SNAP test and, for 19/24 dogs, histologic examination of tissues obtained via endoscopy from the stomach, small intestine, and large intestine. Included dogs had either previously failed evidence‐based treatment, such as multiple adequately performed dietary trials, prebiotics, probiotics, immunosuppressive treatment, FMT, or some combination of these, or responded partially or fully to corticosteroids. Included corticosteroid‐responsive dogs required daily maintenance doses of corticosteroids that were associated with marked adverse effects, such as calcinosis cutis (2/5), hypotrichosis and thin skin (3/5), marked muscle loss (2/5) and weight gain (2/5) [<a href="#jvim70206-bib-0020" class="usa-link" aria-describedby="jvim70206-bib-0020">20</a>, <a href="#jvim70206-bib-0021" class="usa-link" aria-describedby="jvim70206-bib-0021">21</a>, <a href="#jvim70206-bib-0024" class="usa-link" aria-describedby="jvim70206-bib-0024">24</a>]. Antibiotic trials were generally not performed, consistent with recent recommendations [<a href="#jvim70206-bib-0021" class="usa-link" aria-describedby="jvim70206-bib-0021">21</a>, <a href="#jvim70206-bib-0025" class="usa-link" aria-describedby="jvim70206-bib-0025">25</a>]. Dogs with partial response to corticosteroids had experienced a mild decrease in CIBDAI with corticosteroids but continued to have clinical signs that were regarded as cumbersome and deteriorated if treatment was tapered. At least two unsuccessful attempts to taper corticosteroids had been performed in all of these dogs, which were classified as having partially immunosuppressant‐responsive enteropathy (P‐IRE). Exclusion criteria were treatment with antibiotics within 8 weeks before starting cholestyramine or incomplete medical records.</p>
<p>Plasma taurine concentrations were analyzed in a subset of CE and bile acid sequestrant responsive (BASR) dogs during treatment with BAS. The healthy group consisted of 18 staff‐owned dogs from ESAHHS, undergoing fecal donor screening. These dogs had not been treated with antibiotics for a minimum of 6 months and were not receiving any treatments other than ectoparasite prevention and yearly vaccinations.</p>
<p>The CIBDAI was calculated at the baseline visit or retrospectively within 1 month of the baseline visit. The clinical history template at ESAHHS contains all of the anamnestic questions required to calculate CIBDAI. Additionally, fecal consistency was graded from 1 to 7 by the dog owners, using a previously published fecal scoring chart [<a href="#jvim70206-bib-0026" class="usa-link" aria-describedby="jvim70206-bib-0026">26</a>]. Dogs were followed from starting BAS until the time of manuscript submission.</p></section><section id="jvim70206-sec-0011"><h3 class="pmc_sec_title">2.3. Storage and Shipping of Fecal Samples</h3>
<p>Baseline fecal samples, collected by the dog owners for diagnostic purposes, were brought to the ESAHHS in connection with scheduled consultations and were stored at −20°C. If the decision to start BAS treatment was made by phone consultation, the dog owners collected a fecal sample, stored it in a refrigerator, and delivered it to the ESAHHS within 24 h of collection, or stored it in a freezer and brought it to the ESAHHS on cool packs in a cool bag at the next scheduled appointment. Additionally, 31 follow‐up fecal samples during treatment with BAS were available from 13 responders. Samples were shipped on dry ice with priority shipment every 6–12 months to the Gastrointestinal Laboratory at the Texas A&amp;M College of Veterinary Medicine and Biochemical Sciences. The condition of the samples was recorded on arrival, and samples then were stored at −80°C. Internal data show good stability of fecal BAs stored at −80°C for 1.5–4 years (Figure <a href="#jvim70206-supitem-0001" class="usa-link">S1</a>).</p></section><section id="jvim70206-sec-0012"><h3 class="pmc_sec_title">2.4. Fecal Bile Acid Analysis</h3>
<p>Fecal concentrations of 28 BA (including unconjugated, taurine‐ and glycine‐conjugated, and iso‐ and oxo‐BA) were measured using a previously validated liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay [<a href="#jvim70206-bib-0027" class="usa-link" aria-describedby="jvim70206-bib-0027">27</a>]. Primary BA were defined as cholic acid (CA) and chenodeoxycholic acid (CDCA) [<a href="#jvim70206-bib-0028" class="usa-link" aria-describedby="jvim70206-bib-0028">28</a>], and 2BA as deoxycholic acid (DCA) and lithocholic acid (LCA), similar to other reports [<a href="#jvim70206-bib-0004" class="usa-link" aria-describedby="jvim70206-bib-0004">4</a>, <a href="#jvim70206-bib-0029" class="usa-link" aria-describedby="jvim70206-bib-0029">29</a>, <a href="#jvim70206-bib-0030" class="usa-link" aria-describedby="jvim70206-bib-0030">30</a>, <a href="#jvim70206-bib-0031" class="usa-link" aria-describedby="jvim70206-bib-0031">31</a>]. Deoxycholic acid and LCA are produced by microbial biotransformation of 1BA involving 7α‐dehydroxylation enzymes produced by the bile‐acid‐inducible (<em>bai</em>) operon of <em>P. hiranonis</em> in dogs [<a href="#jvim70206-bib-0017" class="usa-link" aria-describedby="jvim70206-bib-0017">17</a>].</p></section><section id="jvim70206-sec-0013"><h3 class="pmc_sec_title">2.5. Bacterial Quantitative Polymerase Chain Reaction (qPCR) Analysis</h3>
<p>Bacterial qPCR analysis was performed on all fecal samples according to a previously described method [<a href="#jvim70206-bib-0018" class="usa-link" aria-describedby="jvim70206-bib-0018">18</a>]. Dysbiosis index (DI) was used to evaluate dysbiosis. This index has been shown to significantly differentiate healthy dogs from dogs with chronic enteropathies and correlate with metagenomic sequencing [<a href="#jvim70206-bib-0018" class="usa-link" aria-describedby="jvim70206-bib-0018">18</a>, <a href="#jvim70206-bib-0032" class="usa-link" aria-describedby="jvim70206-bib-0032">32</a>, <a href="#jvim70206-bib-0033" class="usa-link" aria-describedby="jvim70206-bib-0033">33</a>].</p></section><section id="jvim70206-sec-0014"><h3 class="pmc_sec_title">2.6. Clinical Pathology and Histopathology</h3>
<p>Routine serum biochemistry and hematology was performed at the ESAHHS using Indiko Plus (Thermo Fisher Scientific, Gothenburg, Sweden) and ProCyte Dx (IDEXX GmbH Ludwigsburg, Germany), respectively. Serum cholesterol concentration was compared at baseline and during treatment in responders. If multiple follow‐up samples were available from the same dog, the most recent sample was used for comparison.</p>
<p>Serum cobalamin and folate concentrations were analyzed at the Evidensia Specialist Animal Hospital, Strömsholm, Sweden, using an Immulite 2000, and serum specific canine pancreatic lipase was measured at IDEXX BioAnalytics, Kornwestheim, Germany. For plasma taurine concentration, whole blood samples were collected in cold EDTA tubes, which were immediately put in a refrigerator. Plasma was separated the same day, frozen for a minimum of 24 h, and transported in specially designed freeze packs to the Medizinisches Labor Bremen in Germany. Accidentally thawed samples were discarded.</p></section><section id="jvim70206-sec-0015"><h3 class="pmc_sec_title">2.7. Statistical Analysis</h3>
<p>For this retrospective case series of medical records and laboratory data, based on the recommendation of a statistician, no formal statistical comparisons were employed. Data are presented in a descriptive manner.</p></section></section><section id="jvim70206-sec-0016"><h2 class="pmc_sec_title">3. Results</h2>
<section id="jvim70206-sec-0017"><h3 class="pmc_sec_title">3.1. Study Population</h3>
<p>Twenty‐four dogs with CE and 18 healthy control dogs were included. Age, body weight, sex, breed, body condition score (BCS) and CIBDAI at inclusion are presented in Table <a href="#jvim70206-tbl-0001" class="usa-link">1</a>. Dogs with CE were under treatment for a median of 30 (range, 11–82) months before starting BAS. The main reasons for starting BAS treatment were refractory diarrhea (20/24), abdominal pain, bloating, lip‐smacking, lethargy, borborygmi, and nausea (3/24) and frequent passage of soft feces, urgency, and nightly defecation (1/24). The terms “responders” or CE+BASR (bile acid sequestrant responders) and “non‐responders” or CE−BASR (bile acid sequestrant non‐responders) are used in the remaining text instead of BAD. Non‐responders all had refractory diarrhea. In 12/24 dogs, a second reason for starting BAS was the difficulty in decreasing the corticosteroid dose to an acceptable maintenance dose without recurrence of clinical signs. All dogs had undergone multiple dietary trials before starting BAS, psyllium, or a psyllium‐containing prebiotic and probiotics (Table <a href="#jvim70206-tbl-0001" class="usa-link">1</a>). At inclusion, 21/24 dogs were being treated with corticosteroids, and 20/24 were being treated with second‐line immunosuppressives that were started 75–1151 days before BAS, of which five were receiving treatment with mycophenolate (3–19 mg/kg q24h). Mycophenolate had been added to treat gastrointestinal signs 206–1151 days previously, at a median dosage of 8 mg/kg/day (range, 3–19). This treatment was associated with mild improvement of clinical signs, the possibility to taper corticosteroids slightly, or both, and had not caused worsening of diarrhea in any of the dogs. Previous treatment, discontinued before inclusion, included corticosteroids in 3/24 dogs and alternative second‐line immunosuppressives in 15/24 dogs (Table <a href="#jvim70206-tbl-0001" class="usa-link">1</a>). Regarding phenotype, the population of dogs was fairly heterogeneous. Fourteen of 24 dogs had P‐IRE and six dogs had immunosuppressant‐responsive enteropathy (IRE) but required high doses of corticosteroids, associated with adverse effects described in Section <a href="#jvim70206-sec-0008" class="usa-link">2</a>. The addition of second‐line immunosuppressives had not allowed tapering of corticosteroids in IRE dogs. Four dogs had non‐responsive enteropathy (NRE), of which one had protein‐losing enteropathy with a serum albumin concentration &lt; 20 g/L on multiple occasions. Results from DI analysis with or without fBA were available in nine dogs when the decision to start treatment with BAS was made, but not in the remaining dogs.</p>
<section class="tw xbox font-sm" id="jvim70206-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Selected data of healthy dogs and CE dogs responding to versus not responding to BA sequestrants and at inclusion, including previous treatments and diets.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Parameter (range; median or number)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE+BASR</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE−BASR</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Healthy</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>n</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">18</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3–13.3 (7.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8–8.9 (3.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0–9.8 (4.3)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BW (kg) at inclusion</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.5–53.3 (23.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.5–28.5 (16.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.7–31.1 (14.4)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BCS at inclusion (/9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3–6 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3–7 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–6 (5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Breeds (amount) &gt; 1 dog/group</td>
<td align="center" valign="top" rowspan="1" colspan="1">Havanese (2), Labrador r. (2), Rottweiler (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">English Springer Spaniel (2), Whippet (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Mixed br. (3), Shetland Sheepdog (2), Whippet (2)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sex (M/MN/F/FN)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/6/3/2</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/2/2/1</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/3/8/3</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Phenotype</td>
<td align="center" valign="top" rowspan="1" colspan="1">P‐IRE (10), IRE (4), NRE (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">P‐IRE (4), IRE (2), NRE (1), NRE + PLE (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">H (18)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CIBDAI at inclusion</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–13 (6.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–8 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–2 (1)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fecal score (/7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–7 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–6 (4.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–3 (2)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum albumin (g/L); RI 29–39</td>
<td align="center" valign="top" rowspan="1" colspan="1">24–42 (31)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25–36 (31)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31–39 (33)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Albumin 24–28 g/L</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/16 (31%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/8 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/18</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum total protein (g/L); RI 59–75</td>
<td align="center" valign="top" rowspan="1" colspan="1">43–73 (63)</td>
<td align="center" valign="top" rowspan="1" colspan="1">42–77 (60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total protein below RI</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/16 (6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/8 (25%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum cholesterol (mg/dL); RI 159–282</td>
<td align="center" valign="top" rowspan="1" colspan="1">124–371 (260)</td>
<td align="center" valign="top" rowspan="1" colspan="1">151–398 (273)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cholesterol below RI</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/16 (6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/8 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum ALT activity (U/L); RI 18–78</td>
<td align="center" valign="top" rowspan="1" colspan="1">18–192 (57)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30–288 (51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hematocrit (%), RI 37–62</td>
<td align="center" valign="top" rowspan="1" colspan="1">29–53 (42)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34–63 (44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum cobalamin (ng/L); RI 251–908</td>
<td align="center" valign="top" rowspan="1" colspan="1">267–1000 (578)</td>
<td align="center" valign="top" rowspan="1" colspan="1">373–913 (630)</td>
<td align="center" valign="top" rowspan="1" colspan="1">474–878 (643)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>Serum folate (μg/L);</p>
<p>RI 6.6–19.8</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.4–23.8 (15.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11–23.8 (18.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>Serum cPL (μg/L);</p>
<p>RI 0–200</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">44–2000 (115)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32–208 (55)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diet at inclusion</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">KD; maintenance diet</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">KD: “Intestinal”</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">KD; single protein</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">KD; hydrolyzed</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Home‐cooked</td>
<td align="center" valign="top" rowspan="1" colspan="1">3<a href="#jvim70206-note-0003" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Previous dietary trials/dog</td>
<td align="center" valign="top" rowspan="1" colspan="1">3–7 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3–9 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Type of previous diet</td>
<td align="center" valign="top" rowspan="1" colspan="1">HY (23), SP (20), I (15), HC (5), HF (4), LF (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">HY(13), SP (18), I (7), HC (4), HF (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Treatment at inclusion</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Corticosteroids</td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Started before inclusion (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">471–2496 (1228)</td>
<td align="center" valign="top" rowspan="1" colspan="1">267–1090 (639)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Second line immunosuppressives</td>
<td align="center" valign="top" rowspan="1" colspan="1">CSA (8), MMF (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CHL (3), CSA (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Started before inclusion (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">75–1151 (396)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60–670 (209)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cobalamin supplement</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/16</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/8</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Started before inclusion (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">180–1156 (609)</td>
<td align="center" valign="top" rowspan="1" colspan="1">214–275</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Folate supplement</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/16</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Started before inclusion (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">833</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Prebiotics</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Probiotics</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Previous treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Corticosteroids</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Second line immunosuppressives</td>
<td align="center" valign="top" rowspan="1" colspan="1">AZA (2), CSA (5), MMF (2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">AZA (2), MMF (4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Prebiotic trial (psyllium)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Probiotic trial</td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jvim70206-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jvim70206-note-0002"><p>Abbreviations: +BASR, responsive to bile acid sequestrants; 2nd, second; AZA, azathioprine; BA, bile acid; −BASR, non‐responsive to bile acid sequestrants; BCS, body condition score; BW, body weight; CE, chronic enteropathy; CHL, chlorambucil; CIBDAI, Canine inflammatory bowel disease index; cPL, canine pancreatic lipase; CSA, Cyclosporine A; H, healthy; HC, home‐cooked balanced diet; HF, high‐fiber diet; HY, hydrolyzed protein diet; I, intestinal diet; IRE, immunosuppressive‐responsive enteropathy; KD, kibble diet; LF, low fat diet; MMF, mycophenolate mofetil; n/a, not applicable; NRE, non‐responsive enteropathy; P‐IRE, partially immunosuppressive‐responsive enteropathy; PLE, protein‐losing enteropathy, defined as having serum albumin concentrations below 20 g/L on multiple occasions; RI, reference interval; SP, single protein.</p></div>
<div class="fn" id="jvim70206-note-0003">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Balanced according to AAFCO norms.</p>
</div>
</div></section></section><section id="jvim70206-sec-0018"><h3 class="pmc_sec_title">3.2. Response to Treatment With BAS—CIBDAI and Additional Variables</h3>
<p>The first follow‐up time point was 21–35 days after starting off‐label treatment with BAS. Multiple follow‐up time points were available from all responders. Sixteen of 24 dogs responded to BAS, with a decrease in CIBDAI (Table <a href="#jvim70206-tbl-0002" class="usa-link">2</a>) and CIBDAI category, from severe to mild, moderate to mild, or insignificant, and mild to insignificant (Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a>). Fecal scores decreased from a median of 5 (1–7 out of 7) to a median of 2.5 (2–5 out of 7) during treatment in CE+BASR dogs. Three additional dogs showed improvement of other clinical signs not accounted for in the CIBDAI, such as nocturnal defecation or abdominal pain, bloating, or a swollen abdomen. In nine of 14 CE+BASR dogs treated with corticosteroids at inclusion, the maintenance dose of corticosteroids could be tapered by 33%–67%, which had not been possible before starting BAS. Non‐responders had no decrease in CIBDAI category or fecal scores (Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a> and Table <a href="#jvim70206-tbl-0002" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="jvim70206-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Selected data in CE dogs responding to versus not responding to BA sequestrants.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Parameter (range; median or number)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE+BASR T0</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE+BASR T1</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE−BASR T0</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CE−BASR T1</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CIBDAI</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–13 (6.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2–5 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–8 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–9 (6.5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fecal score (/7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–7 (5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2–5 (2.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–6 (4.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–7 (5)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum albumin (g/L); RI 29–39</td>
<td align="center" valign="top" rowspan="1" colspan="1">24–42 (31)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24–35 (32)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25–36 (31)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Albumin 24–28 g/L</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/16 (31%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/16 (25%)<a href="#jvim70206-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/8 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum cholesterol (mg/dL); RI 159–282</td>
<td align="center" valign="top" rowspan="1" colspan="1">104–371 (260)</td>
<td align="center" valign="top" rowspan="1" colspan="1">166–356<a href="#jvim70206-note-0005" class="usa-link">
<sup>a</sup>
</a> (288)</td>
<td align="center" valign="top" rowspan="1" colspan="1">151–398 (273)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Plasma taurine (μmol/L); RI 44–224</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">16–376<a href="#jvim70206-note-0005" class="usa-link">
<sup>a</sup>
</a> (120)</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Euthanasia for GI reasons</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/16 (25%)<a href="#jvim70206-note-0006" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/8 (50%)<a href="#jvim70206-note-0006" class="usa-link">
<sup>b</sup>
</a>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jvim70206-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jvim70206-note-0004"><p>Abbreviations: +BASR, responsive to bile acid sequestrants; −BASR, non‐responsive to bile acid sequestrants; CE, chronic enteropathy; CIBDAI, Canine inflammatory bowel disease index; T0, baseline; T1, 21–35 days after starting BAS.</p></div>
<div class="fn" id="jvim70206-note-0005">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Latest sample collected.</p>
</div>
<div class="fn" id="jvim70206-note-0006">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Until time of writing.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="jvim70206-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb5/12365994/45d5c29a6cd1/JVIM-39-e70206-g001.jpg" loading="lazy" id="jats-graphic-1" height="1107" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/jvim70206-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CIBDAI categories, fecal BA, DI and abundance of <em>Peptacetobacter hiranonis</em>. CIBDAI categories at baseline and T1 in dogs with CE responding to (A) versus not responding to (B) BA sequestrants. Fecal BA at inclusion (C–F). DI (G) and abundance of <em>P. hiranonis</em> (H) at inclusion. (C) total fBA represent a sum of all BA measured, (D) total 1fBA represent conjugated and unconjugated cholic acid and chenodeoxycholic acid, (E) total 2fBA represent conjugated and unconjugated deoxycholic acid and lithocholic acid, (F) represent the unconjugated 1fBA as a percentage of unconjugated fBA. Bars represent the median. Red dots represent dogs with log10 abundance of <em>P. hiranonis</em> &lt; 4.5. Gray field represent reference interval. BA, bile acid; +BASR, responding to bile acid sequestrants; CE, chronic enteropathy; +BASR, non‐responsive to bile acid sequestrants; CIBDAI, canine inflammatory bowel disease activity index; DI, dysbiosis index; fBA, fecal bile acids; fUBA, fecal unconjugated bile acids; T0, baseline; T1, 21–35 days after starting BAS.</p></figcaption></figure></section><section id="jvim70206-sec-0019"><h3 class="pmc_sec_title">3.3. 
BA Sequestrants and Adverse Effects</h3>
<p>The median (range) starting dose of cholestyramine (Kolestyramin<a href="#jvim70206-note-0009" class="usa-link">
<sup>1</sup>
</a> Alternova, Orifarm Generics AB, Stockholm, Sweden) was 52 (22–79) mg/kg q24h for 5–7 days, which was gradually increased weekly over 3–4 weeks to a maximum dose of 64 (44–133) mg/kg q12h, unless marked adverse gastrointestinal effects occurred. This gradual increase and dose range mirror recommendations in people [<a href="#jvim70206-bib-0034" class="usa-link" aria-describedby="jvim70206-bib-0034">34</a>, <a href="#jvim70206-bib-0035" class="usa-link" aria-describedby="jvim70206-bib-0035">35</a>]. Owners were instructed to give any concurrent medication one hour before BAS or 4–6 h later, as recommended in people [<a href="#jvim70206-bib-0034" class="usa-link" aria-describedby="jvim70206-bib-0034">34</a>, <a href="#jvim70206-bib-0035" class="usa-link" aria-describedby="jvim70206-bib-0035">35</a>]. Seven dogs were treated with second‐generation BAS: 6/7 dogs received colesevelam (Cholestagel<a href="#jvim70206-note-0010" class="usa-link">
<sup>2</sup>
</a>, Cheplapharm, Greifswald, Germany), and 1/7 colestipol (Lestid<a href="#jvim70206-note-0011" class="usa-link">
<sup>3</sup>
</a>, Pfizer, Stockholm, Sweden; no longer available). This decision was based on the lack of clinical response to cholestyramine in 4/7 dogs, palatability issues in 1/7 dogs, and a shortage of cholestyramine in 2/7 dogs. Colesevelam was given at a starting dosage of 5–24 mg/kg (median, 11) q24h, which was gradually increased to 7 to 24 mg/kg (median, 11) q12h. There was limited ability to titrate the colesevelam dose based on the available tablet formulation. Colestipol was given at a dosage of 26 mg/kg q24h. Of the four dogs previously non‐responsive to cholestyramine, one responded to colestipol and one to colesevelam. These two dogs thus were classified as BAS responders. The dog with palatability issues on cholestyramine had a better clinical response to colesevelam than cholestyramine regarding fecal quality and frequency. Adverse effects of cholestyramine were seen in 4/16 responders and 5/8 non‐responders. Two responders vomited on two to three occasions during the first week of treatment, one had increased flatulence, and one dog developed diarrhea, bloating, and signs of abdominal pain on cholestyramine, but tolerated second‐generation BAS well. One dog treated with colesevelam developed melena and worsening of diarrhea at a starting dosage of 20 mg/kg q24h, but later tolerated a starting dose of 5 mg/kg q 24h. Colesevelam then was gradually increased to 15 mg/kg q24h without adverse effects, but with markedly improved fecal quality and decreased flatulence. The only dog treated with colestipol responded clinically to a dosage of 26 mg/kg q24h without adverse effects, but developed diarrhea and a distended abdomen when the dosage was increased to q12h. The dosage then was decreased to q24h again, which had a good effect on clinical signs.</p>
<p>In non‐responders, 4/8 dogs showed worsening of diarrhea and 1/8 dogs developed vomiting and diarrhea. In 3/8 non‐responders, adverse effects occurred when the dosage was increased to q12h. Subsequently, the dosage was decreased to q24h again. Two of the non‐responders had BAS discontinued within 14 days of treatment because of adverse events. Remaining non‐responders continued BAS for a minimum of 4 weeks, without any clinical improvement.</p></section><section id="jvim70206-sec-0020"><h3 class="pmc_sec_title">3.4. Fecal Bile Acid Profiles at Baseline and Follow‐Up</h3>
<p>Samples for baseline fBA were analyzed in 23/24 diseased dogs and 18 healthy dogs (Table <a href="#jvim70206-tbl-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="jvim70206-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Fecal BA in CE+BASR, CE−BASR and healthy dogs.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">ng/mg fecal dry matter or %</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">CE+BASR</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">CE−BASR</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">Healthy</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">Median</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Range</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Median</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Range</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Median</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Range</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total BA</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 881</td>
<td align="center" valign="top" rowspan="1" colspan="1">4362–32 816</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 798</td>
<td align="center" valign="top" rowspan="1" colspan="1">6992–20 642</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 147</td>
<td align="center" valign="top" rowspan="1" colspan="1">3049–21 486</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">% UBA of total BA</td>
<td align="center" valign="top" rowspan="1" colspan="1">99</td>
<td align="center" valign="top" rowspan="1" colspan="1">94–100</td>
<td align="center" valign="top" rowspan="1" colspan="1">99</td>
<td align="center" valign="top" rowspan="1" colspan="1">98–100</td>
<td align="center" valign="top" rowspan="1" colspan="1">99</td>
<td align="center" valign="top" rowspan="1" colspan="1">98–100</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total 1BA</td>
<td align="center" valign="top" rowspan="1" colspan="1">4013</td>
<td align="center" valign="top" rowspan="1" colspan="1">73–16 388</td>
<td align="center" valign="top" rowspan="1" colspan="1">216</td>
<td align="center" valign="top" rowspan="1" colspan="1">25–3321</td>
<td align="center" valign="top" rowspan="1" colspan="1">106</td>
<td align="center" valign="top" rowspan="1" colspan="1">20–1846</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">% 1 UBA of total UBA</td>
<td align="center" valign="top" rowspan="1" colspan="1">93</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–100</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–95</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–19</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total 2BA</td>
<td align="center" valign="top" rowspan="1" colspan="1">540</td>
<td align="center" valign="top" rowspan="1" colspan="1">24–8902</td>
<td align="center" valign="top" rowspan="1" colspan="1">6480</td>
<td align="center" valign="top" rowspan="1" colspan="1">189–9883</td>
<td align="center" valign="top" rowspan="1" colspan="1">6780</td>
<td align="center" valign="top" rowspan="1" colspan="1">2138–9870</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Unconjugated BA (UBA)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cholic acid (CA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3718</td>
<td align="center" valign="top" rowspan="1" colspan="1">32–14 236</td>
<td align="center" valign="top" rowspan="1" colspan="1">148</td>
<td align="center" valign="top" rowspan="1" colspan="1">16–2812</td>
<td align="center" valign="top" rowspan="1" colspan="1">62</td>
<td align="center" valign="top" rowspan="1" colspan="1">10–1699</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3oxo‐CA</td>
<td align="center" valign="top" rowspan="1" colspan="1">52.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–205.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4–50.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3–45.9</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">iso‐CA</td>
<td align="center" valign="top" rowspan="1" colspan="1">106.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.5–832.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">27.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7–85.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7–117.2</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Chenodeoxycholic acid (CDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">269.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.5–2453</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">7–481.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.6–312.3</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3oxo‐CDCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0–45.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0–14.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0–14.0</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Deoxycholic acid (DCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">481</td>
<td align="center" valign="top" rowspan="1" colspan="1">29–8186</td>
<td align="center" valign="top" rowspan="1" colspan="1">5421</td>
<td align="center" valign="top" rowspan="1" colspan="1">172–9361</td>
<td align="center" valign="top" rowspan="1" colspan="1">5183</td>
<td align="center" valign="top" rowspan="1" colspan="1">1593–8419</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3oxo‐DCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–851</td>
<td align="center" valign="top" rowspan="1" colspan="1">582.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">5–4839</td>
<td align="center" valign="top" rowspan="1" colspan="1">682</td>
<td align="center" valign="top" rowspan="1" colspan="1">50–2475</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7oxo‐DCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">1903</td>
<td align="center" valign="top" rowspan="1" colspan="1">8–8232</td>
<td align="center" valign="top" rowspan="1" colspan="1">119</td>
<td align="center" valign="top" rowspan="1" colspan="1">13–2151</td>
<td align="center" valign="top" rowspan="1" colspan="1">53</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–952</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lithocholic acid (LCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4–844</td>
<td align="center" valign="top" rowspan="1" colspan="1">605.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">11–1474</td>
<td align="center" valign="top" rowspan="1" colspan="1">1213</td>
<td align="center" valign="top" rowspan="1" colspan="1">289–3728</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">12oxo‐LCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–2651</td>
<td align="center" valign="top" rowspan="1" colspan="1">781.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">9–4839</td>
<td align="center" valign="top" rowspan="1" colspan="1">1486</td>
<td align="center" valign="top" rowspan="1" colspan="1">90–5079</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3,7,12oxo‐LCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–0.6</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7,12oxo‐LCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4–205.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4–19</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3–21.9</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7oxo‐LCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.8–541.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.4–278</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.8–197.4</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Allo‐LCA</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.0</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hyocholic acid (HCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–3.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–1.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3–4.6</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hyodeoxycholic acid (HDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">1–2205</td>
<td align="center" valign="top" rowspan="1" colspan="1">1804</td>
<td align="center" valign="top" rowspan="1" colspan="1">95–4550</td>
<td align="center" valign="top" rowspan="1" colspan="1">2298</td>
<td align="center" valign="top" rowspan="1" colspan="1">355–7243</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ursocholic acid (UCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–1137</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8–810</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.5–171.4</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ursodeoxycholic acid (UDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6–433</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8–125.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.6–68.7</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Conjugated BA</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glycocholic acid (GCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–19.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–3.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–4.6</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glycochenodeoxycholic acid (GCDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–1.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–3.0</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glycodeoxycholic acid (GDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–5.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–16.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4–22.4</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glycolithocolic acid (GLCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–1.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–4.2</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glycoursodeoxicholic acid (GUDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Taurocholic acid (TCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">27.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.9–171.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.1–20.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6–29.3</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Taurochenodeoxycholic acid (TCDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–43.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2–21.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–6.8</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Taurodeoxycholic acid (TDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–40.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7–121.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5–122.6</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Taurolithocolic acid (TLCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–8</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–16.5</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tauroursodeoxicholic acid (TUDCA)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1–18</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0–5.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–0.7</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jvim70206-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jvim70206-note-0007"><p>
<em>Note:</em> Total BA, sum of all 28 BA; Total 1BA, sum of conjugated and unconjugated cholic acid and chenodeoxycholic acid; Total 2BA, conjugated and unconjugated deoxycholic acid and lithocholic acid; % UBA of total BA, % unconjugated BA of all 28 BA in conjugated or unconjugated form; % 1 UBA of total UBA, % unconjugated cholic acid and chenodeoxycholic acid of all 28 unconjugated BA.</p></div>
<div class="fn" id="jvim70206-note-0008"><p>Abbreviations: BA, bile acids; CE+BASR, chronic enteropathy responding to bile acid sequestrants; CE−BASR, chronic enteropathy non‐responsive to bile acid sequestrants; <em>p</em>, <em>p</em> value; UBA, unconjugated bile acid.</p></div>
</div></section><p>Unconjugated fBA represented 94%–100% of the total fBA in both groups (Table <a href="#jvim70206-tbl-0003" class="usa-link">3</a>).</p>
<p>In healthy dogs and CE‐BASR dogs, the majority of fBA at baseline were 2BA, consistent with previous studies (Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a>) [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0006" class="usa-link" aria-describedby="jvim70206-bib-0006">6</a>, <a href="#jvim70206-bib-0007" class="usa-link" aria-describedby="jvim70206-bib-0007">7</a>]. The amount of 2BA was lower in CE+BASR dogs compared with healthy and CE‐BASR dogs. Dogs responding to BAS had increased abundance of total f1BA and % f1BA as compared with non‐responders and healthy dogs (Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a>) at baseline. Responders had (mean [95% confidence interval (CI)]) increased percentage (69% [47–90]) of unconjugated 1BA versus non‐responders (16% [−11 to 43]) and healthy dogs (4% [1–7]), as well as increased total amount of f1BA (5368 [2481–8256]) versus non‐responders (717 [−246 to 1680]) and healthy dogs (355 [93–617]). Follow‐up fecal samples, collected at various time points, from CE+BASR dogs during treatment were available from 13 dogs. Eleven of 13 dogs had the first follow‐up sample collected 1–4 months after starting BAS. Results are presented with a timeline in Figure <a href="#jvim70206-fig-0002" class="usa-link">2</a>.</p>
<figure class="fig xbox font-sm" id="jvim70206-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb5/12365994/0f0e7153094d/JVIM-39-e70206-g002.jpg" loading="lazy" id="jats-graphic-3" height="569" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/jvim70206-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Fecal unconjugated bile acids, total fecal bile acids, dysbiosis index and abundance of <em>Peptacetobacter hiranonis</em> over time in CE dogs responding to BAS. % 1FUBA represent the unconjugated 1fBA as a percentage of unconjugated fBA. Total fBA represent the sum of all BA measured. Gray field represent reference interval. 1fBA, primary fecal bile acids; +BASR, responding to bile acid sequestrants; −BASR, non‐responsive to bile acid sequestrants; CE, chronic enteropathy; DI, dysbiosis index; fBA, fecal bile acids; fUBA, fecal unconjugated bile acids.</p></figcaption></figure></section><section id="jvim70206-sec-0021"><h3 class="pmc_sec_title">3.5. Microbiota qPCR Analysis</h3>
<p>Fecal samples for DI at baseline were available from all dogs. Median [range] DI in CE+BASR dogs was 4.2 [−4.7 to 9.0], −0.1 [−1.5 to 5.7] in CE‐BASR dogs, and −4.5 [−6.4 to −0.2] in healthy dogs (Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a>). Median [range] abundance of <em>P. hiranonis</em> log DNA was lower in responders (2.0 [0.1–7.2]) versus non‐responders (6.4 [0.1–7.0]) and healthy dogs (6.7 [6.1–7.7]; Figure <a href="#jvim70206-fig-0001" class="usa-link">1</a>). Eleven of 16 CE+BASR dogs had depletion of <em>P. hiranonis</em> at baseline compared with 1/8 CE−BASR dogs and 0/18 healthy dogs. Follow‐up samples during treatment with BAS were available from 14 responders (Figure <a href="#jvim70206-fig-0002" class="usa-link">2</a>).</p></section><section id="jvim70206-sec-0022"><h3 class="pmc_sec_title">3.6. Serum Cholesterol and Plasma Taurine Concentrations</h3>
<p>Serum cholesterol concentrations at baseline and during treatment with BAS were available from 10 responders (Table <a href="#jvim70206-tbl-0002" class="usa-link">2</a>). No marked difference in serum cholesterol concentration was observed at baseline as compared to follow‐up. Two additional dogs lacked baseline samples but had serum cholesterol concentrations within the reference interval (RI) during treatment. Only 1 of 30 serum cholesterol concentrations from 12 dogs during BAS treatment was subnormal. This dog had serum cholesterol concentrations within the RI in several samples collected before and after that time point.</p>
<p>Plasma taurine concentrations during treatment were available from 9 CE+BASR dogs (Table <a href="#jvim70206-tbl-0002" class="usa-link">2</a>). Samples were collected a median of 9 (range, 4–34) months after starting treatment with BAS. Follow‐up plasma taurine concentrations were within or above the RI in 8/9 dogs (RI, 44–224 μmol/L). One asymptomatic dog had a subnormal plasma taurine concentration of 16 μmol/L 7 months after starting cholestyramine. Serum cholesterol concentration was unaltered compared to baseline at this time point. Treatment with cholestyramine was stopped and taurine supplementation was initiated. At follow‐up, the plasma taurine concentration had normalized. Three other dogs had second follow‐up taurine samples. None of these samples had lower serum taurine concentrations than the first follow‐up samples.</p></section><section id="jvim70206-sec-0023"><h3 class="pmc_sec_title">3.7. Long‐Term Follow Up</h3>
<p>Euthanasia because of NRE or severe flare‐up of CE was elected in 4/8 CE−BASR dogs and 4/16 CE+BASR dogs. Seven BAS responders had been euthanized for non‐GI disorders. These dogs could be maintained with 33%–67% lower dosages of corticosteroids than before starting BAS and were clinically more stable until the time of death. The CE+BASR dogs alive at the time of manuscript preparation had a median (range) CIBDAI of 2.5 (2–3) at the last follow‐up visit within 1–6 months of manuscript preparation, which is lower than their corresponding baseline median (range) CIBDAI of 5 (4–8). Additional clinical long‐term follow‐up information is available in Data S4.</p></section></section><section id="jvim70206-sec-0024"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>In this retrospective study, we report the clinical picture and fecal profile in 24 dogs with non‐responsive or partially immunosuppressive‐responsive enteropathy, or CE dogs requiring high dosages of corticosteroids, responding to versus not responding to BAS. Furthermore, we report the long‐term clinical response and adverse effects of treatment with BAS. Sixteen of 24 dogs responded to BAS, with improved fecal scores and decreased CIBDAI category. At baseline, CE+BASR dogs had increased amounts and percentages of f1BA, but not total fBA, compared with non‐responders and healthy dogs. In addition, dogs with CE+BASR had higher DI and lower abundance of <em>P. hiranonis</em> compared with CE−BASR and healthy dogs.</p>
<p>Fecal 1BA differed in CE+BASR from CE−BASR and healthy dogs. The majority of the CE+BASR dogs had depletion of <em>P. hiranonis</em>, a bacterial species that carries the bile acid‐inducible (<em>bai</em>) operon. The <em>bai</em> operon encodes for enzymes that are capable of both deconjugation and dehydroxylation of f1BA into f2BA. A positive correlation among the abundance of <em>P. hiranonis</em>, the <em>bai</em> operon, and f2BA recently has been shown in dogs [<a href="#jvim70206-bib-0004" class="usa-link" aria-describedby="jvim70206-bib-0004">4</a>]. Two separate studies have shown that conversion from f1BA into f2BA requires a log10 abundance of <em>P. hiranonis</em> above a threshold of 4.5 [<a href="#jvim70206-bib-0003" class="usa-link" aria-describedby="jvim70206-bib-0003">3</a>, <a href="#jvim70206-bib-0004" class="usa-link" aria-describedby="jvim70206-bib-0004">4</a>]. This threshold is in agreement with our findings, where all dogs with depletion of <em>P. hiranonis</em> had very low amounts of f2BA compared with CE‐BASR and healthy dogs. Hence, the abundance of <em>P. hiranonis</em> is a good predictor of BA conversion.</p>
<p>Four CE+BASR dogs had a high percentage of f1BA compared with healthy and CE−BASR dogs, despite normal abundance of <em>P. hiranonis</em>. This finding could result from decreased absorptive capacity of the ileum, disruption of the negative feedback loop in BA synthesis, or both, resulting in overproduction of 1BA [<a href="#jvim70206-bib-0010" class="usa-link" aria-describedby="jvim70206-bib-0010">10</a>]. Three additional CE+BASR dogs with chronic diarrhea had neither dysbiosis nor a high amount or percentage of f1BA but responded well to BAS. These dogs may have had other alterations of normal BA cycling or decreased intestinal transit time.</p>
<p>The increased amount of 7oxo‐deoxycholic acid (7oxo‐DCA) and 7oxo‐lithocolic acid (7oxo‐LCA) in some of the CE+BASR dogs may seem surprising, because deoxycholic acid and lithocholic acid are both 2BA. However, the transformation of cholic acid and chenodeoxycholic acid to 7oxo‐DCA and 7oxo‐LCA, respectively, does not involve the <em>bai</em> operon, but rather uses the enzyme 7α‐hydroxysteroid dehydrogenase (HSDH) [<a href="#jvim70206-bib-0029" class="usa-link" aria-describedby="jvim70206-bib-0029">29</a>, <a href="#jvim70206-bib-0036" class="usa-link" aria-describedby="jvim70206-bib-0036">36</a>, <a href="#jvim70206-bib-0037" class="usa-link" aria-describedby="jvim70206-bib-0037">37</a>]. Multiple bacterial taxa, including 
<em>Escherichia coli</em>
 and several <em>Clostridium</em> spp., carry HSDH genes [<a href="#jvim70206-bib-0029" class="usa-link" aria-describedby="jvim70206-bib-0029">29</a>]. Although f1BA can be transformed through oxidation and epimerization by different forms of HSDH, this change only accounts for a small fraction of 1BA conversion compared with 7α‐dehydroxylation via the <em>bai</em> operon in people [<a href="#jvim70206-bib-0029" class="usa-link" aria-describedby="jvim70206-bib-0029">29</a>]. In the CE+BASR dogs, a large amount of 1BA is present in the feces. This situation, combined with depletion of <em>P. hiranonis,</em> potentially could lead to increased utilization of BA transformation via the 7α‐HSDH pathway and corresponding increase in 7oxo‐LCA and 7oxo‐DCA.</p>
<p>The increased amount of f1BA, but not total fBA observed in our study, also has been found in people with IBD [<a href="#jvim70206-bib-0038" class="usa-link" aria-describedby="jvim70206-bib-0038">38</a>]. However, studies in people with irritable bowel syndrome with diarrhea (IBS‐D) have shown an increase in the total amount of fBA in BAD [<a href="#jvim70206-bib-0039" class="usa-link" aria-describedby="jvim70206-bib-0039">39</a>, <a href="#jvim70206-bib-0040" class="usa-link" aria-describedby="jvim70206-bib-0040">40</a>, <a href="#jvim70206-bib-0041" class="usa-link" aria-describedby="jvim70206-bib-0041">41</a>]. It is possible that alterations in fBA are related to which type of BAD affects the patient. Type 1 includes patients with ileal dysfunction (Crohn's disease) or absent ileum; type 2 is primary or idiopathic BAD in patients lacking intestinal morphological abnormalities, such as IBS‐D; and type 3 is BAD secondary to miscellaneous GI disorders, including microscopic colitis, small intestinal bacterial overgrowth, and others. In our observational study, all CE+BASR dogs appeared to be affected as a consequence of CE, with or without intestinal dysbiosis. Flare‐ups of diarrhea, necessitating dose increases or changes of immunomodulatory treatment, still occurred in several dogs during treatment with BAS. In our experience, increasing the dose of BAS usually was not sufficient to decrease disease activity during a flare‐up in these dogs. The often persistently abnormal unconjugated f1BA, DI, and abundance of <em>P. hiranonis</em> in CE+BASR dogs over time suggest that the underlying disease is still present, but clinical signs are dampened by BAS in combination with other treatments.</p>
<p>The CE‐BASR dogs had less marked dysbiosis than the responders. Not all CE dogs have dysbiosis, and we hypothesize that the CE‐BASR dogs have a different phenotype than the CE+BASR dogs.</p>
<p>The ability to decrease the maintenance dose of corticosteroid by 33%–67% after starting BAS treatment in 9/14 CE+BASR dogs is encouraging. Four of these dogs had IRE with previously described marked adverse corticosteroid effects. These adverse effects improved after tapering corticosteroids in these dogs. For the remaining five dogs, two became less heat intolerant, one became more active, one stopped having recurrent urinary tract infections, and one overweight dog lost weight. These findings are consistent with a recent study on BAS treatment in people with microscopic colitis, in which 37 of 45 patients could decrease budesonide after starting BAS [<a href="#jvim70206-bib-0042" class="usa-link" aria-describedby="jvim70206-bib-0042">42</a>]. Studies in healthy people and rats have shown that corticosteroid treatment increases the expression of ASBT up to 30% [<a href="#jvim70206-bib-0043" class="usa-link" aria-describedby="jvim70206-bib-0043">43</a>, <a href="#jvim70206-bib-0044" class="usa-link" aria-describedby="jvim70206-bib-0044">44</a>]. This increase may be a contributing factor to why it was not possible to decrease corticosteroids, despite the addition of second or third line immunosuppressives, in CE+BASR dogs until treatment with BAS was initiated. Other possible explanations include that high doses of corticosteroids were needed to combat inflammation and that binding an excessive amount of 1BA had an anti‐inflammatory effect that enabled tapering of corticosteroids.</p>
<p>Bile acid sequestrants are mainly used for the treatment of primary hypercholesterolemia in people [<a href="#jvim70206-bib-0045" class="usa-link" aria-describedby="jvim70206-bib-0045">45</a>]. Treatment with BAS for chronic diarrhea thus poses a risk of causing hypocholesterolemia. The maintenance doses of BAS used in our study were too low to induce hypocholesterolemia, except for a transient, short‐lasting decrease in one dog on one occasion after cholestyramine had been increased because of a flare‐up. Because the dogs in our study did not develop persistent hypocholesterolemia, we suspect that the risk of developing deficiencies in fat‐soluble vitamins over time is likely low.</p>
<p>Treatment with BAS further poses a risk of taurine deficiency, because cholestyramine in people has a higher affinity for BA conjugated with taurine than for those conjugated with glycine [<a href="#jvim70206-bib-0046" class="usa-link" aria-describedby="jvim70206-bib-0046">46</a>]. One asymptomatic dog in our study was diagnosed with taurine deficiency based on a plasma sample collected after 7 months of BAS treatment. Treatment was stopped, and supplementation with taurine started. Taurine deficiency can contribute to dilated cardiomyopathy and premature death in dogs [<a href="#jvim70206-bib-0047" class="usa-link" aria-describedby="jvim70206-bib-0047">47</a>]. Consequently, it is crucial to monitor plasma taurine concentrations in dogs being treated with BAS or to supplement all dogs treated with BAS with taurine, although 8 of 9 dogs with a known taurine status had normal plasma concentrations. Additional studies are needed to assess the prevalence of iatrogenic taurine deficiency in dogs treated with BAS, especially because taurine deficiency may not be detected by plasma taurine concentrations unless the deficiency is severe [<a href="#jvim70206-bib-0048" class="usa-link" aria-describedby="jvim70206-bib-0048">48</a>, <a href="#jvim70206-bib-0049" class="usa-link" aria-describedby="jvim70206-bib-0049">49</a>].</p>
<p>The clinical response in the CE+BASR dogs varied from a marked decrease in frequency of defecation and improvement in fecal quality to slightly improved frequency of defecation and improved fecal scores or decreased urgency. This variation may correlate with the severity of BAM consistent with data from people. In a systematic review, a dose–response relationship between severity of BAM and clinical response to BAS was shown [<a href="#jvim70206-bib-0050" class="usa-link" aria-describedby="jvim70206-bib-0050">50</a>]. Response to cholestyramine was seen in 96% of the patients with severe BAM, based on the 75‐selenium homocholic acid taurine test, in 80% of patients with moderate BAM and in 70% of patients with mild BAM.</p>
<p>In our observational study, 7/16 dogs responded to second generation BAS, such as colesevelam (6/16) or colestipol (1/16). Two of the dogs previously had not responded to cholestyramine. Colesevelam has reported efficacy in people with BAD who do not respond to cholestyramine or in patients who discontinue cholestyramine because of adverse effects [<a href="#jvim70206-bib-0035" class="usa-link" aria-describedby="jvim70206-bib-0035">35</a>, <a href="#jvim70206-bib-0051" class="usa-link" aria-describedby="jvim70206-bib-0051">51</a>]. Cholestyramine is associated with a high rate of discontinuation in people because of adverse events, even in patients who have clinical improvement of diarrhea [<a href="#jvim70206-bib-0035" class="usa-link" aria-describedby="jvim70206-bib-0035">35</a>, <a href="#jvim70206-bib-0052" class="usa-link" aria-describedby="jvim70206-bib-0052">52</a>, <a href="#jvim70206-bib-0053" class="usa-link" aria-describedby="jvim70206-bib-0053">53</a>]. A very recent prospective randomized trial showed that colesevelam was well tolerated and superior to placebo at inducing remission of BAD in people [<a href="#jvim70206-bib-0054" class="usa-link" aria-describedby="jvim70206-bib-0054">54</a>]. Very little information is available on colesevelam in dogs. In a study in rats and dogs, using radioactively labeled colesevelam, all of the colesevelam was excreted in feces in both species after 28 days of treatment [<a href="#jvim70206-bib-0055" class="usa-link" aria-describedby="jvim70206-bib-0055">55</a>]. An unpublished 28‐day toxicity study of colesevelam in rats and dogs previously was performed by the same group [<a href="#jvim70206-bib-0055" class="usa-link" aria-describedby="jvim70206-bib-0055">55</a>]. No GI lesions were found, in contrast to another study in rats that showed villous atrophy and colonic cell injury after cholestyramine or colestipol treatment [<a href="#jvim70206-bib-0056" class="usa-link" aria-describedby="jvim70206-bib-0056">56</a>]. A document from the European Medicines Agency's scientific evaluation of colesevelam for human consumption is available online and contains data from dogs [<a href="#jvim70206-bib-0057" class="usa-link" aria-describedby="jvim70206-bib-0057">57</a>]. Colesevelam dosages of 300 mg/kg or higher q24h lowered serum cholesterol concentrations in dogs. Toxicity studies lasting 1 year suggested no observed adverse effects at a dosage of 200 mg/kg q24h, and a lowest observed adverse effect dosage of 600 mg/kg q24h. These dosages of colesevelam are markedly higher than the 7–24 mg/kg q12h used in our observational case series. However, colesevelam at a starting dosage of 20 mg/kg was associated with abdominal pain, melena, and mucoid feces in one dog, which required discontinuation of colesevelam and restarting cholestyramine. One year later, the dog refused the cholestyramine, and colesevelam was started at a lower dosage and slowly increased to 15 mg/kg q24h without adverse effects. Furthermore, fecal quality and frequency were improved compared with during cholestyramine treatment.</p>
<p>Normalization of fBA dysmetabolism can occur in some dogs with food‐responsive enteropathy and steroid‐responsive enteropathy after treatment with diet or corticosteroids [<a href="#jvim70206-bib-0005" class="usa-link" aria-describedby="jvim70206-bib-0005">5</a>, <a href="#jvim70206-bib-0017" class="usa-link" aria-describedby="jvim70206-bib-0017">17</a>]. Dogs suspected to have BA dysmetabolism always should be treated with conventional treatment protocols first, including targeted nutritional interventions such as supplemental fiber (e.g., psyllium) [<a href="#jvim70206-bib-0020" class="usa-link" aria-describedby="jvim70206-bib-0020">20</a>, <a href="#jvim70206-bib-0021" class="usa-link" aria-describedby="jvim70206-bib-0021">21</a>]. Psyllium is known to bind fBA and induce expression of genes mediating BA secretion, preventing reabsorption and leading to increased excretion of fBA, and thus acting like a less potent BAS [<a href="#jvim70206-bib-0058" class="usa-link" aria-describedby="jvim70206-bib-0058">58</a>, <a href="#jvim70206-bib-0059" class="usa-link" aria-describedby="jvim70206-bib-0059">59</a>]. All CE dogs in our study had been treated using multiple dietary trials, psyllium, and immunomodulatory treatments before BAS. Thus, persistent clinical signs of CE, persistently increased DI, f1BA, depletion of <em>P. hiranonis</em>, or some combination of these, despite multiple dietary trials, psyllium, and medical treatments are possible indications for considering BAS.</p>
<p>In the CE+BASR group, 3/16 dogs had bloating, lethargy, and abdominal pain as the main clinical signs and only occasional diarrhea. These clinical signs markedly improved with BAS treatment. Similar results have been reported in people with BAM, with subsequent improvement in abdominal pain, flatulence, lethargy, and bloating noted during treatment with BAS [<a href="#jvim70206-bib-0060" class="usa-link" aria-describedby="jvim70206-bib-0060">60</a>].</p>
<p>Our study had several limitations, mostly related to its retrospective design and small sample size. Neither samples for cholesterol and taurine determination nor long‐term follow‐up fecal samples were available from all CE+BASR dogs. The time point for obtaining follow‐up samples also varied. Furthermore, the decision to start BAS was influenced by results from DI or fBA or both in 9/24 CE dogs. Consequently, this population may not represent a general population of dogs with IRE, NRE, or P‐IRE. Additionally, concurrent treatments were not standardized, and groups were heterogeneous. Multiple treatments were given in parallel with BAS, without a wash‐out period. However, the responders had been on the same medical treatment for 75–1151 (median, 396) days before starting BAS, and diet was not changed for a minimum of 4 months, making clinical improvement more likely related to BAS than a late onset effect of concurrent treatment.</p>
<p>Despite these limitations, the results of our study may be useful when designing prospective studies on treatment using BAS in CE dogs partially or completely refractory to other treatments, or requiring high doses of corticosteroids, and having a suspicion of BAM. Bile acid sequestrants target a previously rarely addressed pathophysiology in dogs with CE. When more data is available, the addition of BAS in dogs with refractory CE may contribute to decreasing the number of dogs euthanized for NRE or decreasing disease activity in P‐IRE dogs.</p></section><section id="jvim70206-sec-0026"><h2 class="pmc_sec_title">Disclosure</h2>
<p>The authors declare no off‐label use of antimicrobials.</p></section><section id="jvim70206-sec-0027"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The authors declare no institutional animal care and use committee or other approval was needed. The authors declare human ethics approval was not needed.</p></section><section id="jvim70206-sec-0028"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Linda Toresson, Amanda B. Blake, Chi‐Hsuan Sung, M. Katherine Tolbert, and Jan S. Suchodolski work for the Gastrointestinal Laboratory at Texas A&amp;M University that analyzes dysbiosis index on a fee for service basis. The other authors declare no conflicts of interest.</p></section><section id="sec28"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="jvim70206-supitem-0001"><div class="caption p">
<p>
<strong>Data S1:</strong> 1A. Histopathologic diagnosis in 12 CE dogs responding to bile acid sequestrants. All biopsies were retrieved endoscopically. Biopses from the small intestine were not available in 1 out of 12 dogs. Biopsies were analyzed according to the guidelines from the World Small Animal Veterinary Association Gastrointestinal Standardization Group.</p>
<p>
<strong>Data S2:</strong> Commercial diets at inclusion in 13 CE dogs responding to bile acid sequestrants (CE+BASR) and 8 CE dogs not responding to bile acid sequestrants (CE−BASR). Three dogs responding to bile acid sequestrants were fed a balanced home‐cooked diet.</p>
<p>
<strong>Data S3:</strong>. Stability of percentage of fecal unconjugated primary bile acids over time in fecal samples stored in −80°C. Samples stored for 1.5–4 years (median 2.5).</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12365994/bin/JVIM-39-e70206-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">JVIM-39-e70206-s002.docx</a><sup> (41.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="jvim70206-supitem-0002"><div class="caption p"><p>
<strong>Data S4:</strong> Long‐term follow up data of CE dogs treated with BAS.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12365994/bin/JVIM-39-e70206-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JVIM-39-e70206-s001.docx</a><sup> (13.2KB, docx) </sup>
</div></div></section></section><section id="jvim70206-sec-0025" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors thank the Purina PetCare Research Excellence Fund, the Swedish Veterinary Care Foundation and the Ulla Yard Foundation for financial support, as well as the participating dog owners and laboratory staff at the Evidensia Specialist Animal Hospital, Helsingborg, Sweden.</p></section><section id="notes1"><p>

Toresson L., Blake A. B., Sung C.‐H., et al., “Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series,” Journal of Veterinary Internal Medicine
39, no. 5 (2025): e70206, 10.1111/jvim.70206.
</p>
<section id="jvim70206-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="jvim70206-note-0001"><p>
<strong>Funding:</strong> This work was supported by Purina PetCare Research Excellence Fund, Ulla Yard Foundation and Swedish Veterinary Care Foundation.</p></div></div></section></section><section id="jvim70206-ntgp-0005" class="fn-group"><h2 class="pmc_sec_title">Endnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="jvim70206-note-0009">
<sup>
<sup>1</sup>
</sup><p class="display-inline">Kolestyramin Alternova (4 g), Orifarm Generics, Odense, Denmark.</p>
</div>
<div class="fn p" id="jvim70206-note-0010">
<sup>
<sup>2</sup>
</sup><p class="display-inline">Cholestagel (625 mg), Cheplapharm, Greifswald, Germany.</p>
</div>
<div class="fn p" id="jvim70206-note-0011">
<sup>
<sup>3</sup>
</sup><p class="display-inline">Lestid (1 g), Pfizer, Sollentuna, Sweden.</p>
</div>
</div></section><section id="jvim70206-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="jvim70206-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="jvim70206-bib-0001">
<span class="label">1.</span><cite>
Hofmann A. F., “The Syndrome of Ileal Disease and the Broken Enterohepatic Circulation: Cholerheic Enteropathy,” Gastroenterology
52, no. 4 (1967): 752–757.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/5337211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=The%20Syndrome%20of%20Ileal%20Disease%20and%20the%20Broken%20Enterohepatic%20Circulation:%20Cholerheic%20Enteropathy&amp;author=A.%20F.%20Hofmann&amp;volume=52&amp;issue=4&amp;publication_year=1967&amp;pages=752-757&amp;pmid=5337211&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0002">
<span class="label">2.</span><cite>
Kitahara M., Takamine F., Imamura T., and Benno Y., “
<em>Clostridium hiranonis</em> sp. Nov., a Human Intestinal Bacterium With Bile Acid 7alpha‐Dehydroxylating Activity,” International Journal of Systematic and Evolutionary Microbiology
51, no. Pt 1 (2001): 39–44, 10.1099/00207713-51-1-39.
</cite> [<a href="https://doi.org/10.1099/00207713-51-1-39" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11211270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Systematic%20and%20Evolutionary%20Microbiology&amp;title=Clostridium%20hiranonis%20sp.%20Nov.,%20a%20Human%20Intestinal%20Bacterium%20With%20Bile%20Acid%207alpha%E2%80%90Dehydroxylating%20Activity&amp;author=M.%20Kitahara&amp;author=F.%20Takamine&amp;author=T.%20Imamura&amp;author=Y.%20Benno&amp;volume=51&amp;issue=Pt%201&amp;publication_year=2001&amp;pages=39-44&amp;pmid=11211270&amp;doi=10.1099/00207713-51-1-39&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0003">
<span class="label">3.</span><cite>
Li Q., Larouche‐Lebel É., Loughran K. A., Huh T. P., Suchodolski J. S., and Oyama M. A., “Gut Dysbiosis and Its Associations With Gut Microbiota‐Derived Metabolites in Dogs With Myxomatous Mitral Valve Disease,” MSystems
6, no. 2 (2021): e00111–e00121, 10.1128/mSystems.00111-21.
</cite> [<a href="https://doi.org/10.1128/mSystems.00111-21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8546968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33879495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MSystems&amp;title=Gut%20Dysbiosis%20and%20Its%20Associations%20With%20Gut%20Microbiota%E2%80%90Derived%20Metabolites%20in%20Dogs%20With%20Myxomatous%20Mitral%20Valve%20Disease&amp;author=Q.%20Li&amp;author=%C3%89.%20Larouche%E2%80%90Lebel&amp;author=K.%20A.%20Loughran&amp;author=T.%20P.%20Huh&amp;author=J.%20S.%20Suchodolski&amp;volume=6&amp;issue=2&amp;publication_year=2021&amp;pages=e00111-e00121&amp;pmid=33879495&amp;doi=10.1128/mSystems.00111-21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0004">
<span class="label">4.</span><cite>
Correa Lopes B., Chen C. C., Sung C. H., et al., “Correlation Between Peptacetobacter Hiranonis, the baiCD Gene, and Secondary Bile Acids in Dogs,” Animals
14, no. 2 (2024): 216, 10.3390/ani14020216.
</cite> [<a href="https://doi.org/10.3390/ani14020216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10812727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38254385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Animals&amp;title=Correlation%20Between%20Peptacetobacter%20Hiranonis,%20the%20baiCD%20Gene,%20and%20Secondary%20Bile%20Acids%20in%20Dogs&amp;author=B.%20Correa%20Lopes&amp;author=C.%20C.%20Chen&amp;author=C.%20H.%20Sung&amp;volume=14&amp;issue=2&amp;publication_year=2024&amp;pages=216&amp;pmid=38254385&amp;doi=10.3390/ani14020216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0005">
<span class="label">5.</span><cite>
Guard B. C., Honneffer J. B., Jergens A. E., et al., “Longitudinal Assessment of Microbial Dysbiosis, Fecal Unconjugated Bile Acid Concentrations, and Disease Activity in Dogs With Steroid‐Responsive Chronic Inflammatory Enteropathy,” Journal of Veterinary Internal Medicine
33, no. 3 (2019): 1295–1305, 10.1111/jvim.15493.
</cite> [<a href="https://doi.org/10.1111/jvim.15493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6524081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30957301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Longitudinal%20Assessment%20of%20Microbial%20Dysbiosis,%20Fecal%20Unconjugated%20Bile%20Acid%20Concentrations,%20and%20Disease%20Activity%20in%20Dogs%20With%20Steroid%E2%80%90Responsive%20Chronic%20Inflammatory%20Enteropathy&amp;author=B.%20C.%20Guard&amp;author=J.%20B.%20Honneffer&amp;author=A.%20E.%20Jergens&amp;volume=33&amp;issue=3&amp;publication_year=2019&amp;pages=1295-1305&amp;pmid=30957301&amp;doi=10.1111/jvim.15493&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0006">
<span class="label">6.</span><cite>
Blake A. B., Guard B. C., Honneffer J. B., Lidbury J. A., Steiner J. M., and Suchodolski J. S., “Altered Microbiota, Fecal Lactate, and Fecal Bile Acids in Dogs With Gastrointestinal Disease,” PLoS One
14, no. 10 (2019): e0224454, 10.1371/journal.pone.0224454.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0224454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6822739/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31671166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Altered%20Microbiota,%20Fecal%20Lactate,%20and%20Fecal%20Bile%20Acids%20in%20Dogs%20With%20Gastrointestinal%20Disease&amp;author=A.%20B.%20Blake&amp;author=B.%20C.%20Guard&amp;author=J.%20B.%20Honneffer&amp;author=J.%20A.%20Lidbury&amp;author=J.%20M.%20Steiner&amp;volume=14&amp;issue=10&amp;publication_year=2019&amp;pages=e0224454&amp;pmid=31671166&amp;doi=10.1371/journal.pone.0224454&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0007">
<span class="label">7.</span><cite>
Comito R., Porru E., Interino N., et al., “Metabolic Bile Acid Profile Impairments in Dogs Affected by Chronic Inflammatory Enteropathy,” Metabolites
13, no. 9 (2023): 980, 10.3390/metabo13090980.
</cite> [<a href="https://doi.org/10.3390/metabo13090980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10535270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37755260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolites&amp;title=Metabolic%20Bile%20Acid%20Profile%20Impairments%20in%20Dogs%20Affected%20by%20Chronic%20Inflammatory%20Enteropathy&amp;author=R.%20Comito&amp;author=E.%20Porru&amp;author=N.%20Interino&amp;volume=13&amp;issue=9&amp;publication_year=2023&amp;pages=980&amp;pmid=37755260&amp;doi=10.3390/metabo13090980&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0008">
<span class="label">8.</span><cite>
Sciarretta G., Fagioli G., Furno A., et al., “75Se HCAT Test in the Detection of Bile Acid Malabsorption in Functional Diarrhoea and Its Correlation With Small Bowel Transit,” Gut
28, no. 8 (1987): 970–975, 10.1136/gut.28.8.970.
</cite> [<a href="https://doi.org/10.1136/gut.28.8.970" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1433129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3666565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=75Se%20HCAT%20Test%20in%20the%20Detection%20of%20Bile%20Acid%20Malabsorption%20in%20Functional%20Diarrhoea%20and%20Its%20Correlation%20With%20Small%20Bowel%20Transit&amp;author=G.%20Sciarretta&amp;author=G.%20Fagioli&amp;author=A.%20Furno&amp;volume=28&amp;issue=8&amp;publication_year=1987&amp;pages=970-975&amp;pmid=3666565&amp;doi=10.1136/gut.28.8.970&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0009">
<span class="label">9.</span><cite>
Mottacki N., Simrén M., and Bajor A., “Review Article: Bile Acid Diarrhoea—Pathogenesis, Diagnosis and Management,” Alimentary Pharmacology &amp; Therapeutics
43, no. 8 (2016): 884–898, 10.1111/apt.13570.
</cite> [<a href="https://doi.org/10.1111/apt.13570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26913381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alimentary%20Pharmacology%20&amp;%20Therapeutics&amp;title=Review%20Article:%20Bile%20Acid%20Diarrhoea%E2%80%94Pathogenesis,%20Diagnosis%20and%20Management&amp;author=N.%20Mottacki&amp;author=M.%20Simr%C3%A9n&amp;author=A.%20Bajor&amp;volume=43&amp;issue=8&amp;publication_year=2016&amp;pages=884-898&amp;pmid=26913381&amp;doi=10.1111/apt.13570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0010">
<span class="label">10.</span><cite>
Farrugia A. and Arasaradnam R., “Bile Acid Diarrhoea: Pathophysiology, Diagnosis and Management,” Frontline Gastroenterology
12, no. 6 (2021): 500–507, 10.1136/flgastro-2020-101436.
</cite> [<a href="https://doi.org/10.1136/flgastro-2020-101436" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8515273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34712468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontline%20Gastroenterology&amp;title=Bile%20Acid%20Diarrhoea:%20Pathophysiology,%20Diagnosis%20and%20Management&amp;author=A.%20Farrugia&amp;author=R.%20Arasaradnam&amp;volume=12&amp;issue=6&amp;publication_year=2021&amp;pages=500-507&amp;pmid=34712468&amp;doi=10.1136/flgastro-2020-101436&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0011">
<span class="label">11.</span><cite>
Walters J. R. F. and Pattni S. S., “Managing Bile Acid Diarrhoea,” Therapeutic Advances in Gastroenterology
3, no. 6 (2010): 349–357, 10.1177/1756283X10377126.
</cite> [<a href="https://doi.org/10.1177/1756283X10377126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3002596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21180614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Therapeutic%20Advances%20in%20Gastroenterology&amp;title=Managing%20Bile%20Acid%20Diarrhoea&amp;author=J.%20R.%20F.%20Walters&amp;author=S.%20S.%20Pattni&amp;volume=3&amp;issue=6&amp;publication_year=2010&amp;pages=349-357&amp;pmid=21180614&amp;doi=10.1177/1756283X10377126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0012">
<span class="label">12.</span><cite>
Khalid U., Lalji A., Stafferton R., and Andreyev J., “Bile Acid Malabsoption: A Forgotten Diagnosis?,” Clinical Medicine
10, no. 2 (2010): 124–126, 10.7861/clinmedicine.10-2-124.
</cite> [<a href="https://doi.org/10.7861/clinmedicine.10-2-124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4952080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20437979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Medicine&amp;title=Bile%20Acid%20Malabsoption:%20A%20Forgotten%20Diagnosis?&amp;author=U.%20Khalid&amp;author=A.%20Lalji&amp;author=R.%20Stafferton&amp;author=J.%20Andreyev&amp;volume=10&amp;issue=2&amp;publication_year=2010&amp;pages=124-126&amp;pmid=20437979&amp;doi=10.7861/clinmedicine.10-2-124&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0013">
<span class="label">13.</span><cite>
Kent A. C. C., Cross G., Taylor D. R., Sherwood R. A., and Watson P. J., “Measurement of Serum 7α‐Hydroxy‐4‐Cholesten‐3‐One as a Marker of Bile Acid Malabsorption in Dogs With Chronic Diarrhoea: A Pilot Study,” Veterinary Record Open
3, no. 1 (2016): e000163, 10.1136/vetreco-2015-000163.
</cite> [<a href="https://doi.org/10.1136/vetreco-2015-000163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4838766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27110372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Veterinary%20Record%20Open&amp;title=Measurement%20of%20Serum%207%CE%B1%E2%80%90Hydroxy%E2%80%904%E2%80%90Cholesten%E2%80%903%E2%80%90One%20as%20a%20Marker%20of%20Bile%20Acid%20Malabsorption%20in%20Dogs%20With%20Chronic%20Diarrhoea:%20A%20Pilot%20Study&amp;author=A.%20C.%20C.%20Kent&amp;author=G.%20Cross&amp;author=D.%20R.%20Taylor&amp;author=R.%20A.%20Sherwood&amp;author=P.%20J.%20Watson&amp;volume=3&amp;issue=1&amp;publication_year=2016&amp;pages=e000163&amp;pmid=27110372&amp;doi=10.1136/vetreco-2015-000163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0014">
<span class="label">14.</span><cite>
Camilleri M., “Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy,” Gut Liver
9, no. 3 (2015): 332–339, 10.5009/gnl14397.
</cite> [<a href="https://doi.org/10.5009/gnl14397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4413966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25918262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut%20Liver&amp;title=Bile%20Acid%20Diarrhea:%20Prevalence,%20Pathogenesis,%20and%20Therapy&amp;author=M.%20Camilleri&amp;volume=9&amp;issue=3&amp;publication_year=2015&amp;pages=332-339&amp;pmid=25918262&amp;doi=10.5009/gnl14397&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0015">
<span class="label">15.</span><cite>
Schiller L. R., “Good News About BAD,” Clinical Gastroenterology and Hepatology
18, no. 1 (2020): 45–47, 10.1016/j.cgh.2019.10.031.
</cite> [<a href="https://doi.org/10.1016/j.cgh.2019.10.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31676357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology&amp;title=Good%20News%20About%20BAD&amp;author=L.%20R.%20Schiller&amp;volume=18&amp;issue=1&amp;publication_year=2020&amp;pages=45-47&amp;pmid=31676357&amp;doi=10.1016/j.cgh.2019.10.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0016">
<span class="label">16.</span><cite>
Giaretta P. R., Rech R. R., Guard B. C., et al., “Comparison of Intestinal Expression of the Apical Sodium‐Dependent Bile Acid Transporter Between Dogs With and Without Chronic Inflammatory Enteropathy,” Journal of Veterinary Internal Medicine
32, no. 6 (2018): 1918–1926, 10.1111/jvim.15332.
</cite> [<a href="https://doi.org/10.1111/jvim.15332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6271328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30315593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Comparison%20of%20Intestinal%20Expression%20of%20the%20Apical%20Sodium%E2%80%90Dependent%20Bile%20Acid%20Transporter%20Between%20Dogs%20With%20and%20Without%20Chronic%20Inflammatory%20Enteropathy&amp;author=P.%20R.%20Giaretta&amp;author=R.%20R.%20Rech&amp;author=B.%20C.%20Guard&amp;volume=32&amp;issue=6&amp;publication_year=2018&amp;pages=1918-1926&amp;pmid=30315593&amp;doi=10.1111/jvim.15332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0017">
<span class="label">17.</span><cite>
Wang S., Martins R., Sullivan M. C., et al., “Diet‐Induced Remission in Chronic Enteropathy Is Associated With Altered Microbial Community Structure and Synthesis of Secondary Bile Acids,” Microbiome
7, no. 1 (2019): 126, 10.1186/s40168-019-0740-4.
</cite> [<a href="https://doi.org/10.1186/s40168-019-0740-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6717631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31472697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microbiome&amp;title=Diet%E2%80%90Induced%20Remission%20in%20Chronic%20Enteropathy%20Is%20Associated%20With%20Altered%20Microbial%20Community%20Structure%20and%20Synthesis%20of%20Secondary%20Bile%20Acids&amp;author=S.%20Wang&amp;author=R.%20Martins&amp;author=M.%20C.%20Sullivan&amp;volume=7&amp;issue=1&amp;publication_year=2019&amp;pages=126&amp;pmid=31472697&amp;doi=10.1186/s40168-019-0740-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0018">
<span class="label">18.</span><cite>
AlShawaqfeh M. K., Wajid B., Minamoto Y., et al., “A Dysbiosis Index to Assess Microbial Changes in Fecal Samples of Dogs With Chronic Inflammatory Enteropathy,” FEMS Microbiology Ecology
93, no. 11 (2017): 1–7, 10.1093/femsec/fix136.</cite> [<a href="https://doi.org/10.1093/femsec/fix136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29040443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEMS%20Microbiology%20Ecology&amp;title=A%20Dysbiosis%20Index%20to%20Assess%20Microbial%20Changes%20in%20Fecal%20Samples%20of%20Dogs%20With%20Chronic%20Inflammatory%20Enteropathy&amp;author=M.%20K.%20AlShawaqfeh&amp;author=B.%20Wajid&amp;author=Y.%20Minamoto&amp;volume=93&amp;issue=11&amp;publication_year=2017&amp;pages=1-7&amp;pmid=29040443&amp;doi=10.1093/femsec/fix136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0019">
<span class="label">19.</span><cite>
Toresson L., Steiner J. M., and Suchodolski J. S., “Cholestyramine Treatment in Two Dogs With Presumptive Bile Acid Diarrhoea: A Case Report,” Canine Medicine and Genetics
8, no. 1 (2021): 1, 10.1186/s40575-021-00099-x.
</cite> [<a href="https://doi.org/10.1186/s40575-021-00099-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7814458/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33468234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canine%20Medicine%20and%20Genetics&amp;title=Cholestyramine%20Treatment%20in%20Two%20Dogs%20With%20Presumptive%20Bile%20Acid%20Diarrhoea:%20A%20Case%20Report&amp;author=L.%20Toresson&amp;author=J.%20M.%20Steiner&amp;author=J.%20S.%20Suchodolski&amp;volume=8&amp;issue=1&amp;publication_year=2021&amp;pages=1&amp;pmid=33468234&amp;doi=10.1186/s40575-021-00099-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0020">
<span class="label">20.</span><cite>
Makielski K., Cullen J., O'Connor A., and Jergens A. E., “Narrative Review of Therapies for Chronic Enteropathies in Dogs and Cats,” Journal of Veterinary Internal Medicine
33, no. 1 (2019): 11–22, 10.1111/jvim.15345.
</cite> [<a href="https://doi.org/10.1111/jvim.15345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6335544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30523666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Narrative%20Review%20of%20Therapies%20for%20Chronic%20Enteropathies%20in%20Dogs%20and%20Cats&amp;author=K.%20Makielski&amp;author=J.%20Cullen&amp;author=A.%20O'Connor&amp;author=A.%20E.%20Jergens&amp;volume=33&amp;issue=1&amp;publication_year=2019&amp;pages=11-22&amp;pmid=30523666&amp;doi=10.1111/jvim.15345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0021">
<span class="label">21.</span><cite>
Jergens A. E. and Heilmann R. M., “Canine Chronic Enteropathy‐Current State‐Of‐The‐Art and Emerging Concepts,” Frontiers in Veterinary Science
9 (2022): 923013, 10.3389/fvets.2022.923013.
</cite> [<a href="https://doi.org/10.3389/fvets.2022.923013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9534534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36213409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Veterinary%20Science&amp;title=Canine%20Chronic%20Enteropathy%E2%80%90Current%20State%E2%80%90Of%E2%80%90The%E2%80%90Art%20and%20Emerging%20Concepts&amp;author=A.%20E.%20Jergens&amp;author=R.%20M.%20Heilmann&amp;volume=9&amp;publication_year=2022&amp;pages=923013&amp;pmid=36213409&amp;doi=10.3389/fvets.2022.923013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0022">
<span class="label">22.</span><cite>
Allenspach K., Rüfenacht S., Sauter S., et al., “Pharmacokinetics and Clinical Efficacy of Cyclosporine Treatment of Dogs With Steroid‐Refractory Inflammatory Bowel Disease,” Journal of Veterinary Internal Medicine
20, no. 2 (2006): 239–244, 10.1892/0891-6640(2006)20[239:paceoc]2.0.co;2.
</cite> [<a href="https://doi.org/10.1892/0891-6640(2006)20%5B239:paceoc%5D2.0.co;2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16594578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Pharmacokinetics%20and%20Clinical%20Efficacy%20of%20Cyclosporine%20Treatment%20of%20Dogs%20With%20Steroid%E2%80%90Refractory%20Inflammatory%20Bowel%20Disease&amp;author=K.%20Allenspach&amp;author=S.%20R%C3%BCfenacht&amp;author=S.%20Sauter&amp;volume=20&amp;issue=2&amp;publication_year=2006&amp;pages=239-244&amp;pmid=16594578&amp;doi=10.1892/0891-6640(2006)20%5B239:paceoc%5D2.0.co;2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0023">
<span class="label">23.</span><cite>
Jergens A. E., Schreiner C. A., Frank D. E., et al., “A Scoring Index for Disease Activity in Canine Inflammatory Bowel Disease,” Journal of Veterinary Internal Medicine
17, no. 3 (2003): 291–297, 10.1111/j.1939-1676.2003.tb02450.x.
</cite> [<a href="https://doi.org/10.1111/j.1939-1676.2003.tb02450.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12774968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=A%20Scoring%20Index%20for%20Disease%20Activity%20in%20Canine%20Inflammatory%20Bowel%20Disease&amp;author=A.%20E.%20Jergens&amp;author=C.%20A.%20Schreiner&amp;author=D.%20E.%20Frank&amp;volume=17&amp;issue=3&amp;publication_year=2003&amp;pages=291-297&amp;pmid=12774968&amp;doi=10.1111/j.1939-1676.2003.tb02450.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0024">
<span class="label">24.</span><cite>
Toresson L., Spillmann T., Pilla R., et al., “Clinical Effects of Faecal Microbiota Transplantation as Adjunctive Therapy in Dogs With Chronic Enteropathies—A Retrospective Case Series of 41 Dogs,” Veterinary Sciences
10, no. 4 (2023): 271, 10.3390/vetsci10040271.
</cite> [<a href="https://doi.org/10.3390/vetsci10040271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10145442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37104426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Veterinary%20Sciences&amp;title=Clinical%20Effects%20of%20Faecal%20Microbiota%20Transplantation%20as%20Adjunctive%20Therapy%20in%20Dogs%20With%20Chronic%20Enteropathies%E2%80%94A%20Retrospective%20Case%20Series%20of%2041%20Dogs&amp;author=L.%20Toresson&amp;author=T.%20Spillmann&amp;author=R.%20Pilla&amp;volume=10&amp;issue=4&amp;publication_year=2023&amp;pages=271&amp;pmid=37104426&amp;doi=10.3390/vetsci10040271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0025">
<span class="label">25.</span><cite>
Cerquetella M., Rossi G., Suchodolski J. S., et al., “Proposal for Rational Antibacterial Use in the Diagnosis and Treatment of Dogs With Chronic Diarrhoea,” Journal of Small Animal Practice
61, no. 4 (2020): 211–215, 10.1111/jsap.13122.
</cite> [<a href="https://doi.org/10.1111/jsap.13122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7079140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32065388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Small%20Animal%20Practice&amp;title=Proposal%20for%20Rational%20Antibacterial%20Use%20in%20the%20Diagnosis%20and%20Treatment%20of%20Dogs%20With%20Chronic%20Diarrhoea&amp;author=M.%20Cerquetella&amp;author=G.%20Rossi&amp;author=J.%20S.%20Suchodolski&amp;volume=61&amp;issue=4&amp;publication_year=2020&amp;pages=211-215&amp;pmid=32065388&amp;doi=10.1111/jsap.13122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0026">
<span class="label">26.</span><cite>
Lappin M. R., Zug A., Hovenga C., Gagne J., and Cross E., “Efficacy of Feeding a Diet Containing a High Concentration of Mixed Fiber Sources for Management of Acute Large Bowel Diarrhea in Dogs in Shelters,” Journal of Veterinary Internal Medicine
36, no. 2 (2022): 488–492, 10.1111/jvim.16360.
</cite> [<a href="https://doi.org/10.1111/jvim.16360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8965269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35174561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Efficacy%20of%20Feeding%20a%20Diet%20Containing%20a%20High%20Concentration%20of%20Mixed%20Fiber%20Sources%20for%20Management%20of%20Acute%20Large%20Bowel%20Diarrhea%20in%20Dogs%20in%20Shelters&amp;author=M.%20R.%20Lappin&amp;author=A.%20Zug&amp;author=C.%20Hovenga&amp;author=J.%20Gagne&amp;author=E.%20Cross&amp;volume=36&amp;issue=2&amp;publication_year=2022&amp;pages=488-492&amp;pmid=35174561&amp;doi=10.1111/jvim.16360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0027">
<span class="label">27.</span><cite>
Blake A. B., Toresson L. C., Chen C. C., et al., “Altered Iso‐ and Oxo‐Fecal Bile Acid Concentrations in Dogs With Chronic Enteropathy,” Pets
2, no. 2 (2025): 18, 10.3390/pets2020018.</cite> [<a href="https://doi.org/10.3390/pets2020018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pets&amp;title=Altered%20Iso%E2%80%90%20and%20Oxo%E2%80%90Fecal%20Bile%20Acid%20Concentrations%20in%20Dogs%20With%20Chronic%20Enteropathy&amp;author=A.%20B.%20Blake&amp;author=L.%20C.%20Toresson&amp;author=C.%20C.%20Chen&amp;volume=2&amp;issue=2&amp;publication_year=2025&amp;pages=18&amp;doi=10.3390/pets2020018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0028">
<span class="label">28.</span><cite>
Hoffman N. E., Donald D. E., and Hosmann A. F., “Effect of Primary Bile Acids on Bile Lipid Secretion From Perfused Dog Liver,” American Journal of Physiology
229, no. 3 (1975): 714–720, 10.1152/ajplegacy.1975.229.3.714.
</cite> [<a href="https://doi.org/10.1152/ajplegacy.1975.229.3.714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1211466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology&amp;title=Effect%20of%20Primary%20Bile%20Acids%20on%20Bile%20Lipid%20Secretion%20From%20Perfused%20Dog%20Liver&amp;author=N.%20E.%20Hoffman&amp;author=D.%20E.%20Donald&amp;author=A.%20F.%20Hosmann&amp;volume=229&amp;issue=3&amp;publication_year=1975&amp;pages=714-720&amp;pmid=1211466&amp;doi=10.1152/ajplegacy.1975.229.3.714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0029">
<span class="label">29.</span><cite>
Ridlon J. M., Kang D. J., and Hylemon P. B., “Bile Salt Biotransformations by Human Intestinal Bacteria,” Journal of Lipid Research
47, no. 2 (2006): 241–259, 10.1194/jlr.R500013-JLR200.
</cite> [<a href="https://doi.org/10.1194/jlr.R500013-JLR200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16299351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Lipid%20Research&amp;title=Bile%20Salt%20Biotransformations%20by%20Human%20Intestinal%20Bacteria&amp;author=J.%20M.%20Ridlon&amp;author=D.%20J.%20Kang&amp;author=P.%20B.%20Hylemon&amp;volume=47&amp;issue=2&amp;publication_year=2006&amp;pages=241-259&amp;pmid=16299351&amp;doi=10.1194/jlr.R500013-JLR200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0030">
<span class="label">30.</span><cite>
Di Ciaula A., Garruti G., Lunardi Baccetto R., et al., “Bile Acid Physiology,” Annals of Hepatology
16 (2017): S4–S14, 10.5604/01.3001.0010.5493.
</cite> [<a href="https://doi.org/10.5604/01.3001.0010.5493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29080336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Hepatology&amp;title=Bile%20Acid%20Physiology&amp;author=A.%20Di%20Ciaula&amp;author=G.%20Garruti&amp;author=R.%20Lunardi%20Baccetto&amp;volume=16&amp;publication_year=2017&amp;pages=S4-S14&amp;pmid=29080336&amp;doi=10.5604/01.3001.0010.5493&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0031">
<span class="label">31.</span><cite>
Jackson M. I. and Jewell D. E., “Balance of Saccharolysis and Proteolysis Underpins Improvements in Stool Quality Induced by Adding a Fiber Bundle Containing Bound Polyphenols to Either Hydrolyzed Meat or Grain‐Rich Foods,” Gut Microbes
10, no. 3 (2019): 298–320, 10.1080/19490976.2018.1526580.
</cite> [<a href="https://doi.org/10.1080/19490976.2018.1526580" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30376392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut%20Microbes&amp;title=Balance%20of%20Saccharolysis%20and%20Proteolysis%20Underpins%20Improvements%20in%20Stool%20Quality%20Induced%20by%20Adding%20a%20Fiber%20Bundle%20Containing%20Bound%20Polyphenols%20to%20Either%20Hydrolyzed%20Meat%20or%20Grain%E2%80%90Rich%20Foods&amp;author=M.%20I.%20Jackson&amp;author=D.%20E.%20Jewell&amp;volume=10&amp;issue=3&amp;publication_year=2019&amp;pages=298-320&amp;pmid=30376392&amp;doi=10.1080/19490976.2018.1526580&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0032">
<span class="label">32.</span><cite>
Werner M., Suchodolski J. S., Lidbury J. A., Steiner J. M., Hartmann K., and Unterer S., “Diagnostic Value of Fecal Cultures in Dogs With Chronic Diarrhea,” Journal of Veterinary Internal Medicine
35, no. 1 (2021): 199–208, 10.1111/jvim.15982.
</cite> [<a href="https://doi.org/10.1111/jvim.15982" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7848338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33277779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Veterinary%20Internal%20Medicine&amp;title=Diagnostic%20Value%20of%20Fecal%20Cultures%20in%20Dogs%20With%20Chronic%20Diarrhea&amp;author=M.%20Werner&amp;author=J.%20S.%20Suchodolski&amp;author=J.%20A.%20Lidbury&amp;author=J.%20M.%20Steiner&amp;author=K.%20Hartmann&amp;volume=35&amp;issue=1&amp;publication_year=2021&amp;pages=199-208&amp;pmid=33277779&amp;doi=10.1111/jvim.15982&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0033">
<span class="label">33.</span><cite>
Sung C. H., Pilla R., Chen C. C., et al., “Correlation Between Targeted qPCR Assays and Untargeted DNA Shotgun Metagenomic Sequencing for Assessing the Fecal Microbiota in Dogs,” Animals
13, no. 16 (2023): 2597, 10.3390/ani13162597.
</cite> [<a href="https://doi.org/10.3390/ani13162597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10451198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37627387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Animals&amp;title=Correlation%20Between%20Targeted%20qPCR%20Assays%20and%20Untargeted%20DNA%20Shotgun%20Metagenomic%20Sequencing%20for%20Assessing%20the%20Fecal%20Microbiota%20in%20Dogs&amp;author=C.%20H.%20Sung&amp;author=R.%20Pilla&amp;author=C.%20C.%20Chen&amp;volume=13&amp;issue=16&amp;publication_year=2023&amp;pages=2597&amp;pmid=37627387&amp;doi=10.3390/ani13162597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0034">
<span class="label">34.</span><cite>
Barkun A. N., Love J., Gould M., Pluta H., and Steinhart H., “Bile Acid Malabsorption in Chronic Diarrhea: Pathophysiology and Treatment,” Canadian Journal of Gastroenterology
27, no. 11 (2013): 653–659, 10.1155/2013/485631.
</cite> [<a href="https://doi.org/10.1155/2013/485631" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3816948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24199211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Journal%20of%20Gastroenterology&amp;title=Bile%20Acid%20Malabsorption%20in%20Chronic%20Diarrhea:%20Pathophysiology%20and%20Treatment&amp;author=A.%20N.%20Barkun&amp;author=J.%20Love&amp;author=M.%20Gould&amp;author=H.%20Pluta&amp;author=H.%20Steinhart&amp;volume=27&amp;issue=11&amp;publication_year=2013&amp;pages=653-659&amp;pmid=24199211&amp;doi=10.1155/2013/485631&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0035">
<span class="label">35.</span><cite>
Orekoya O., McLaughlin J., Leitao E., Johns W., Lal S., and Paine P., “Quantifying Bile Acid Malabsorption Helps Predict Response and Tailor Sequestrant Therapy,” Clinical Medicine
15, no. 3 (2015): 252–257, 10.7861/clinmedicine.15-3-252.
</cite> [<a href="https://doi.org/10.7861/clinmedicine.15-3-252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4953109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26031975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Medicine&amp;title=Quantifying%20Bile%20Acid%20Malabsorption%20Helps%20Predict%20Response%20and%20Tailor%20Sequestrant%20Therapy&amp;author=O.%20Orekoya&amp;author=J.%20McLaughlin&amp;author=E.%20Leitao&amp;author=W.%20Johns&amp;author=S.%20Lal&amp;volume=15&amp;issue=3&amp;publication_year=2015&amp;pages=252-257&amp;pmid=26031975&amp;doi=10.7861/clinmedicine.15-3-252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0036">
<span class="label">36.</span><cite>
Fukiya S., Arata M., Kawashima H., et al., “Conversion of Cholic Acid and Chenodeoxycholic Acid Into Their 7‐Oxo Derivatives by <em>Bacteroides intestinalis</em> AM‐1 Isolated From Human Feces,” FEMS Microbiology Letters
293, no. 2 (2009): 263–270, 10.1111/j.1574-6968.2009.01531.x.
</cite> [<a href="https://doi.org/10.1111/j.1574-6968.2009.01531.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19243441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEMS%20Microbiology%20Letters&amp;title=Conversion%20of%20Cholic%20Acid%20and%20Chenodeoxycholic%20Acid%20Into%20Their%207%E2%80%90Oxo%20Derivatives%20by%20Bacteroides%20intestinalis%20AM%E2%80%901%20Isolated%20From%20Human%20Feces&amp;author=S.%20Fukiya&amp;author=M.%20Arata&amp;author=H.%20Kawashima&amp;volume=293&amp;issue=2&amp;publication_year=2009&amp;pages=263-270&amp;pmid=19243441&amp;doi=10.1111/j.1574-6968.2009.01531.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0037">
<span class="label">37.</span><cite>
Lucas L. N., Barrett K., Kerby R. L., et al., “Dominant Bacterial Phyla From the Human Gut Show Widespread Ability to Transform and Conjugate Bile Acids,” MSystems
6, no. 4 (2021): e0080521, 10.1128/mSystems.00805-21.</cite> [<a href="https://doi.org/10.1128/mSystems.00805-21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12338150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34463573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MSystems&amp;title=Dominant%20Bacterial%20Phyla%20From%20the%20Human%20Gut%20Show%20Widespread%20Ability%20to%20Transform%20and%20Conjugate%20Bile%20Acids&amp;author=L.%20N.%20Lucas&amp;author=K.%20Barrett&amp;author=R.%20L.%20Kerby&amp;volume=6&amp;issue=4&amp;publication_year=2021&amp;pages=e0080521&amp;pmid=34463573&amp;doi=10.1128/mSystems.00805-21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0038">
<span class="label">38.</span><cite>
Duboc H., Rajca S., Rainteau D., et al., “Connecting Dysbiosis, Bile‐Acid Dysmetabolism and Gut Inflammation in Inflammatory Bowel Diseases,” Gut
62, no. 4 (2013): 531–539, 10.1136/gutjnl-2012-302578.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2012-302578" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22993202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Connecting%20Dysbiosis,%20Bile%E2%80%90Acid%20Dysmetabolism%20and%20Gut%20Inflammation%20in%20Inflammatory%20Bowel%20Diseases&amp;author=H.%20Duboc&amp;author=S.%20Rajca&amp;author=D.%20Rainteau&amp;volume=62&amp;issue=4&amp;publication_year=2013&amp;pages=531-539&amp;pmid=22993202&amp;doi=10.1136/gutjnl-2012-302578&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0039">
<span class="label">39.</span><cite>
Shin A., Camilleri M., Vijayvargiya P., et al., “Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome,” Clinical Gastroenterology and Hepatology: An Official Clinical Practice Journal of the American Gastroenterological Association
11, no. 10 (2013): 1270–1275, 10.1016/j.cgh.2013.04.020.</cite> [<a href="https://doi.org/10.1016/j.cgh.2013.04.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3778140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23639599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology:%20An%20Official%20Clinical%20Practice%20Journal%20of%20the%20American%20Gastroenterological%20Association&amp;title=Bowel%20Functions,%20Fecal%20Unconjugated%20Primary%20and%20Secondary%20Bile%20Acids,%20and%20Colonic%20Transit%20in%20Patients%20With%20Irritable%20Bowel%20Syndrome&amp;author=A.%20Shin&amp;author=M.%20Camilleri&amp;author=P.%20Vijayvargiya&amp;volume=11&amp;issue=10&amp;publication_year=2013&amp;pages=1270-1275&amp;pmid=23639599&amp;doi=10.1016/j.cgh.2013.04.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0040">
<span class="label">40.</span><cite>
Camilleri M., Busciglio I., Acosta A., et al., “Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome‐Diarrhea,” American Journal of Gastroenterology
109, no. 10 (2014): 1621–1630, 10.1038/ajg.2014.215.
</cite> [<a href="https://doi.org/10.1038/ajg.2014.215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6994231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25070056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Gastroenterology&amp;title=Effect%20of%20Increased%20Bile%20Acid%20Synthesis%20or%20Fecal%20Excretion%20in%20Irritable%20Bowel%20Syndrome%E2%80%90Diarrhea&amp;author=M.%20Camilleri&amp;author=I.%20Busciglio&amp;author=A.%20Acosta&amp;volume=109&amp;issue=10&amp;publication_year=2014&amp;pages=1621-1630&amp;pmid=25070056&amp;doi=10.1038/ajg.2014.215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0041">
<span class="label">41.</span><cite>
Vijayvargiya P., Camilleri M., Chedid V., et al., “Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea,” Clinical Gastroenterology and Hepatology: An Official Clinical Practice Journal of the American Gastroenterological Association
17, no. 5 (2019): 922–929, 10.1016/j.cgh.2018.05.050.</cite> [<a href="https://doi.org/10.1016/j.cgh.2018.05.050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6291372/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29902647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology:%20An%20Official%20Clinical%20Practice%20Journal%20of%20the%20American%20Gastroenterological%20Association&amp;title=Analysis%20of%20Fecal%20Primary%20Bile%20Acids%20Detects%20Increased%20Stool%20Weight%20and%20Colonic%20Transit%20in%20Patients%20With%20Chronic%20Functional%20Diarrhea&amp;author=P.%20Vijayvargiya&amp;author=M.%20Camilleri&amp;author=V.%20Chedid&amp;volume=17&amp;issue=5&amp;publication_year=2019&amp;pages=922-929&amp;pmid=29902647&amp;doi=10.1016/j.cgh.2018.05.050&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0042">
<span class="label">42.</span><cite>
Tome J., Sehgal K., Kamboj A. K., Harmsen W. S., Khanna S., and Pardi D. S., “Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing,” Clinical Gastroenterology and Hepatology: An Official Clinical Practice Journal of the American Gastroenterological Association
21, no. 12 (2023): 3125–3131, 10.1016/j.cgh.2023.04.031.</cite> [<a href="https://doi.org/10.1016/j.cgh.2023.04.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37172800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology:%20An%20Official%20Clinical%20Practice%20Journal%20of%20the%20American%20Gastroenterological%20Association&amp;title=Bile%20Acid%20Sequestrants%20in%20Microscopic%20Colitis:%20Clinical%20Outcomes%20and%20Utility%20of%20Bile%20Acid%20Testing&amp;author=J.%20Tome&amp;author=K.%20Sehgal&amp;author=A.%20K.%20Kamboj&amp;author=W.%20S.%20Harmsen&amp;author=S.%20Khanna&amp;volume=21&amp;issue=12&amp;publication_year=2023&amp;pages=3125-3131&amp;pmid=37172800&amp;doi=10.1016/j.cgh.2023.04.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0043">
<span class="label">43.</span><cite>
Nowicki M. J., Shneider B. L., Paul J. M., and Heubi J. E., “Glucocorticoids Upregulate Taurocholate Transport by Ileal Brush‐Border Membrane,” American Journal of Physiology
273, no. 1 Pt 1 (1997): G197–G203, 10.1152/ajpgi.1997.273.1.G197.
</cite> [<a href="https://doi.org/10.1152/ajpgi.1997.273.1.G197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9252527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology&amp;title=Glucocorticoids%20Upregulate%20Taurocholate%20Transport%20by%20Ileal%20Brush%E2%80%90Border%20Membrane&amp;author=M.%20J.%20Nowicki&amp;author=B.%20L.%20Shneider&amp;author=J.%20M.%20Paul&amp;author=J.%20E.%20Heubi&amp;volume=273&amp;issue=1%20Pt%201&amp;publication_year=1997&amp;pages=G197-G203&amp;pmid=9252527&amp;doi=10.1152/ajpgi.1997.273.1.G197&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0044">
<span class="label">44.</span><cite>
Jung D., Fantin A. C., Scheurer U., Fried M., and Kullak‐Ublick G. A., “Human Ileal Bile Acid Transporter Gene ASBT (SLC10A2) is Transactivated by the Glucocorticoid Receptor,” Gut
53, no. 1 (2004): 78–84, 10.1136/gut.53.1.78.
</cite> [<a href="https://doi.org/10.1136/gut.53.1.78" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1773940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14684580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Human%20Ileal%20Bile%20Acid%20Transporter%20Gene%20ASBT%20(SLC10A2)%20is%20Transactivated%20by%20the%20Glucocorticoid%20Receptor&amp;author=D.%20Jung&amp;author=A.%20C.%20Fantin&amp;author=U.%20Scheurer&amp;author=M.%20Fried&amp;author=G.%20A.%20Kullak%E2%80%90Ublick&amp;volume=53&amp;issue=1&amp;publication_year=2004&amp;pages=78-84&amp;pmid=14684580&amp;doi=10.1136/gut.53.1.78&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0045">
<span class="label">45.</span><cite>
Scaldaferri F., Pizzoferrato M., Ponziani F. R., Gasbarrini G., and Gasbarrini A., “Use and Indications of Cholestyramine and Bile Acid Sequestrants,” Internal and Emergency Medicine
8, no. 3 (2013): 205–210, 10.1007/s11739-011-0653-0.
</cite> [<a href="https://doi.org/10.1007/s11739-011-0653-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21739227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Internal%20and%20Emergency%20Medicine&amp;title=Use%20and%20Indications%20of%20Cholestyramine%20and%20Bile%20Acid%20Sequestrants&amp;author=F.%20Scaldaferri&amp;author=M.%20Pizzoferrato&amp;author=F.%20R.%20Ponziani&amp;author=G.%20Gasbarrini&amp;author=A.%20Gasbarrini&amp;volume=8&amp;issue=3&amp;publication_year=2013&amp;pages=205-210&amp;pmid=21739227&amp;doi=10.1007/s11739-011-0653-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0046">
<span class="label">46.</span><cite>
Garbutt J. T. and Kenney T. J., “Effect of Cholestyramine on Bile Acid Metabolism in Normal Man,” Journal of Clinical Investigation
51, no. 11 (1972): 2781–2789, 10.1172/JCI107100.
</cite> [<a href="https://doi.org/10.1172/JCI107100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC292426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/5080408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Effect%20of%20Cholestyramine%20on%20Bile%20Acid%20Metabolism%20in%20Normal%20Man&amp;author=J.%20T.%20Garbutt&amp;author=T.%20J.%20Kenney&amp;volume=51&amp;issue=11&amp;publication_year=1972&amp;pages=2781-2789&amp;pmid=5080408&amp;doi=10.1172/JCI107100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0047">
<span class="label">47.</span><cite>
McCauley S. R., Clark S. D., Quest B. W., Streeter R. M., and Oxford E. M., “Review of Canine Dilated Cardiomyopathy in the Wake of Diet‐Associated Concerns,” Journal of Animal Science
98, no. 6 (2020): skaa155, 10.1093/jas/skaa155.
</cite> [<a href="https://doi.org/10.1093/jas/skaa155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7447921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32542359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Animal%20Science&amp;title=Review%20of%20Canine%20Dilated%20Cardiomyopathy%20in%20the%20Wake%20of%20Diet%E2%80%90Associated%20Concerns&amp;author=S.%20R.%20McCauley&amp;author=S.%20D.%20Clark&amp;author=B.%20W.%20Quest&amp;author=R.%20M.%20Streeter&amp;author=E.%20M.%20Oxford&amp;volume=98&amp;issue=6&amp;publication_year=2020&amp;pages=skaa155&amp;pmid=32542359&amp;doi=10.1093/jas/skaa155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0048">
<span class="label">48.</span><cite>
Tôrres C. L., Biourge V. C., and Backus R. C., “Plasma and Whole Blood Taurine Concentrations in Dogs May Not be Sensitive Indicators of Taurine Deficiency When Dietary Sulfur Amino Acid Content Is Reduced,” Frontiers in Veterinary Science
9 (2022): 873460, 10.3389/fvets.2022.873460.
</cite> [<a href="https://doi.org/10.3389/fvets.2022.873460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9125078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35615252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Veterinary%20Science&amp;title=Plasma%20and%20Whole%20Blood%20Taurine%20Concentrations%20in%20Dogs%20May%20Not%20be%20Sensitive%20Indicators%20of%20Taurine%20Deficiency%20When%20Dietary%20Sulfur%20Amino%20Acid%20Content%20Is%20Reduced&amp;author=C.%20L.%20T%C3%B4rres&amp;author=V.%20C.%20Biourge&amp;author=R.%20C.%20Backus&amp;volume=9&amp;publication_year=2022&amp;pages=873460&amp;pmid=35615252&amp;doi=10.3389/fvets.2022.873460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0049">
<span class="label">49.</span><cite>
McCauley S. R., Clark S. D., Leach S. B., Quest B. W., and Streeter R. M., “Evaluation of Taurine and Carnitine Concentrations in Whole Blood, Plasma, Skeletal Muscle and Cardiac Muscle in Dogs,” Journal of Animal Physiology and Animal Nutrition
108, no. 4 (2024): 999–1015, 10.1111/jpn.13946.
</cite> [<a href="https://doi.org/10.1111/jpn.13946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38432690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Animal%20Physiology%20and%20Animal%20Nutrition&amp;title=Evaluation%20of%20Taurine%20and%20Carnitine%20Concentrations%20in%20Whole%20Blood,%20Plasma,%20Skeletal%20Muscle%20and%20Cardiac%20Muscle%20in%20Dogs&amp;author=S.%20R.%20McCauley&amp;author=S.%20D.%20Clark&amp;author=S.%20B.%20Leach&amp;author=B.%20W.%20Quest&amp;author=R.%20M.%20Streeter&amp;volume=108&amp;issue=4&amp;publication_year=2024&amp;pages=999-1015&amp;pmid=38432690&amp;doi=10.1111/jpn.13946&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0050">
<span class="label">50.</span><cite>
Wedlake L., A'Hern R., Russell D., Thomas K., Walters J. R. F., and Andreyev H. J. N., “Systematic Review: The Prevalence of Idiopathic Bile Acid Malabsorption as Diagnosed by SeHCAT Scanning in Patients With Diarrhoea‐Predominant Irritable Bowel Syndrome,” Alimentary Pharmacology &amp; Therapeutics
30, no. 7 (2009): 707–717, 10.1111/j.1365-2036.2009.04081.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2036.2009.04081.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19570102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alimentary%20Pharmacology%20&amp;%20Therapeutics&amp;title=Systematic%20Review:%20The%20Prevalence%20of%20Idiopathic%20Bile%20Acid%20Malabsorption%20as%20Diagnosed%20by%20SeHCAT%20Scanning%20in%20Patients%20With%20Diarrhoea%E2%80%90Predominant%20Irritable%20Bowel%20Syndrome&amp;author=L.%20Wedlake&amp;author=R.%20A'Hern&amp;author=D.%20Russell&amp;author=K.%20Thomas&amp;author=J.%20R.%20F.%20Walters&amp;volume=30&amp;issue=7&amp;publication_year=2009&amp;pages=707-717&amp;pmid=19570102&amp;doi=10.1111/j.1365-2036.2009.04081.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0051">
<span class="label">51.</span><cite>
Wedlake L., Thomas K., Lalji A., Anagnostopoulos C., and Andreyev H. J. N., “Effectiveness and Tolerability of Colesevelam Hydrochloride for Bile‐Acid Malabsorption in Patients With Cancer: A Retrospective Chart Review and Patient Questionnaire,” Clinical Therapeutics
31, no. 11 (2009): 2549–2558, 10.1016/j.clinthera.2009.11.027.
</cite> [<a href="https://doi.org/10.1016/j.clinthera.2009.11.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20109999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Therapeutics&amp;title=Effectiveness%20and%20Tolerability%20of%20Colesevelam%20Hydrochloride%20for%20Bile%E2%80%90Acid%20Malabsorption%20in%20Patients%20With%20Cancer:%20A%20Retrospective%20Chart%20Review%20and%20Patient%20Questionnaire&amp;author=L.%20Wedlake&amp;author=K.%20Thomas&amp;author=A.%20Lalji&amp;author=C.%20Anagnostopoulos&amp;author=H.%20J.%20N.%20Andreyev&amp;volume=31&amp;issue=11&amp;publication_year=2009&amp;pages=2549-2558&amp;pmid=20109999&amp;doi=10.1016/j.clinthera.2009.11.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0052">
<span class="label">52.</span><cite>
Rössel P., Sortsøe Jensen H., Qvist P., and Arveschoug A., “Prognosis of Adult‐Onset Idiopathic Bile Acid Malabsorption,” Scandinavian Journal of Gastroenterology
34, no. 6 (1999): 587–590, 10.1080/003655299750026047.
</cite> [<a href="https://doi.org/10.1080/003655299750026047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10440608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scandinavian%20Journal%20of%20Gastroenterology&amp;title=Prognosis%20of%20Adult%E2%80%90Onset%20Idiopathic%20Bile%20Acid%20Malabsorption&amp;author=P.%20R%C3%B6ssel&amp;author=H.%20Sorts%C3%B8e%20Jensen&amp;author=P.%20Qvist&amp;author=A.%20Arveschoug&amp;volume=34&amp;issue=6&amp;publication_year=1999&amp;pages=587-590&amp;pmid=10440608&amp;doi=10.1080/003655299750026047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0053">
<span class="label">53.</span><cite>
Flores V., Martínez‐Lozano H., Bighelli F., et al., “Prevalence of Biliary Acid Malabsorption in Patients With Chronic Diarrhoea of Functional Characteristics: A Prospective Study,” BMC Gastroenterology
21, no. 1 (2021): 56, 10.1186/s12876-021-01637-4.
</cite> [<a href="https://doi.org/10.1186/s12876-021-01637-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7871394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33563227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Gastroenterology&amp;title=Prevalence%20of%20Biliary%20Acid%20Malabsorption%20in%20Patients%20With%20Chronic%20Diarrhoea%20of%20Functional%20Characteristics:%20A%20Prospective%20Study&amp;author=V.%20Flores&amp;author=H.%20Mart%C3%ADnez%E2%80%90Lozano&amp;author=F.%20Bighelli&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=56&amp;pmid=33563227&amp;doi=10.1186/s12876-021-01637-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0054">
<span class="label">54.</span><cite>
Borup C., Vinter‐Jensen L., Jørgensen S. P. G., et al., “Efficacy and Safety of Colesevelam for the Treatment of Bile Acid Diarrhoea: A Double‐Blind, Randomised, Placebo‐Controlled, Phase 4 Clinical Trial,” Lancet Gastroenterology &amp; Hepatology
8, no. 4 (2023): 321–331, 10.1016/S2468-1253(22)00401-0.
</cite> [<a href="https://doi.org/10.1016/S2468-1253(22)00401-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36758570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Gastroenterology%20&amp;%20Hepatology&amp;title=Efficacy%20and%20Safety%20of%20Colesevelam%20for%20the%20Treatment%20of%20Bile%20Acid%20Diarrhoea:%20A%20Double%E2%80%90Blind,%20Randomised,%20Placebo%E2%80%90Controlled,%20Phase%204%20Clinical%20Trial&amp;author=C.%20Borup&amp;author=L.%20Vinter%E2%80%90Jensen&amp;author=S.%20P.%20G.%20J%C3%B8rgensen&amp;volume=8&amp;issue=4&amp;publication_year=2023&amp;pages=321-331&amp;pmid=36758570&amp;doi=10.1016/S2468-1253(22)00401-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0055">
<span class="label">55.</span><cite>
Rosenbaum D. P., Petersen J. S., Ducharme S., Markham P., and Goldberg D. I., “Absorption, Distribution and Excretion of GT31‐104, a Novel Bile Acid Sequestrant, in Rats and Dogs After Acute and Subchronic Administration,” Journal of Pharmaceutical Sciences
86, no. 5 (1997): 591–595, 10.1021/js9603820.
</cite> [<a href="https://doi.org/10.1021/js9603820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9145384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmaceutical%20Sciences&amp;title=Absorption,%20Distribution%20and%20Excretion%20of%20GT31%E2%80%90104,%20a%20Novel%20Bile%20Acid%20Sequestrant,%20in%20Rats%20and%20Dogs%20After%20Acute%20and%20Subchronic%20Administration&amp;author=D.%20P.%20Rosenbaum&amp;author=J.%20S.%20Petersen&amp;author=S.%20Ducharme&amp;author=P.%20Markham&amp;author=D.%20I.%20Goldberg&amp;volume=86&amp;issue=5&amp;publication_year=1997&amp;pages=591-595&amp;pmid=9145384&amp;doi=10.1021/js9603820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0056">
<span class="label">56.</span><cite>
Cassidy M. M., Lightfoot F. G., and Vahouny G. V., “Morphological Aspects of Dietary Fibers in the Intestine,” in Advances in Lipid Research, vol. 19 (Elsevier, 1982), 203–229, 10.1016/B978-0-12-024919-0.50013-8.
</cite> [<a href="https://doi.org/10.1016/B978-0-12-024919-0.50013-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6299069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Advances%20in%20Lipid%20Research&amp;author=M.%20M.%20Cassidy&amp;author=F.%20G.%20Lightfoot&amp;author=G.%20V.%20Vahouny&amp;publication_year=1982&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0057">
<span class="label">57.</span><cite>
European Medicines Agency
, “Cholestagel, INN‐Colesevelam,” accessed January 10, 2024, <a href="https://www.ema.europa.eu/en/documents/scientific-discussion/cholestagel-epar-scientific-discussion_en.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ema.europa.eu/en/documents/scientific‐discussion/cholestagel‐epar‐scientific‐discussion_en.pdf</a>.</cite>
</li>
<li id="jvim70206-bib-0058">
<span class="label">58.</span><cite>
Buhman K. K., Furumoto E. J., Donkin S. S., and Story J. A., “Dietary Psyllium Increases Fecal Bile Acid Excretion, Total Steroid Excretion and Bile Acid Biosynthesis in Rats,” Journal of Nutrition
128, no. 7 (1998): 1199–1203, 10.1093/jn/128.7.1199.
</cite> [<a href="https://doi.org/10.1093/jn/128.7.1199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9649606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Nutrition&amp;title=Dietary%20Psyllium%20Increases%20Fecal%20Bile%20Acid%20Excretion,%20Total%20Steroid%20Excretion%20and%20Bile%20Acid%20Biosynthesis%20in%20Rats&amp;author=K.%20K.%20Buhman&amp;author=E.%20J.%20Furumoto&amp;author=S.%20S.%20Donkin&amp;author=J.%20A.%20Story&amp;volume=128&amp;issue=7&amp;publication_year=1998&amp;pages=1199-1203&amp;pmid=9649606&amp;doi=10.1093/jn/128.7.1199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0059">
<span class="label">59.</span><cite>
Bretin A., Zou J., San Yeoh B., et al., “Psyllium Fiber Protects Against Colitis via Activation of Bile Acid Sensor Farnesoid X Receptor,” Cellular and Molecular Gastroenterology and Hepatology
15, no. 6 (2023): 1421–1442, 10.1016/j.jcmgh.2023.02.007.
</cite> [<a href="https://doi.org/10.1016/j.jcmgh.2023.02.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10148163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36828279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Gastroenterology%20and%20Hepatology&amp;title=Psyllium%20Fiber%20Protects%20Against%20Colitis%20via%20Activation%20of%20Bile%20Acid%20Sensor%20Farnesoid%20X%20Receptor&amp;author=A.%20Bretin&amp;author=J.%20Zou&amp;author=B.%20San%20Yeoh&amp;volume=15&amp;issue=6&amp;publication_year=2023&amp;pages=1421-1442&amp;pmid=36828279&amp;doi=10.1016/j.jcmgh.2023.02.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jvim70206-bib-0060">
<span class="label">60.</span><cite>
Gupta A., Muls A. C., Lalji A., et al., “Outcomes From Treating Bile Acid Malabsorption Using a Multidisciplinary Approach,” Support Care Cancer Off J Multinatl Assoc Support Care Cancer
23, no. 10 (2015): 2881–2890, 10.1007/s00520-015-2653-5.</cite> [<a href="https://doi.org/10.1007/s00520-015-2653-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25693765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Support%20Care%20Cancer%20Off%20J%20Multinatl%20Assoc%20Support%20Care%20Cancer&amp;title=Outcomes%20From%20Treating%20Bile%20Acid%20Malabsorption%20Using%20a%20Multidisciplinary%20Approach&amp;author=A.%20Gupta&amp;author=A.%20C.%20Muls&amp;author=A.%20Lalji&amp;volume=23&amp;issue=10&amp;publication_year=2015&amp;pages=2881-2890&amp;pmid=25693765&amp;doi=10.1007/s00520-015-2653-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>
<strong>Data S1:</strong> 1A. Histopathologic diagnosis in 12 CE dogs responding to bile acid sequestrants. All biopsies were retrieved endoscopically. Biopses from the small intestine were not available in 1 out of 12 dogs. Biopsies were analyzed according to the guidelines from the World Small Animal Veterinary Association Gastrointestinal Standardization Group.</p>
<p>
<strong>Data S2:</strong> Commercial diets at inclusion in 13 CE dogs responding to bile acid sequestrants (CE+BASR) and 8 CE dogs not responding to bile acid sequestrants (CE−BASR). Three dogs responding to bile acid sequestrants were fed a balanced home‐cooked diet.</p>
<p>
<strong>Data S3:</strong>. Stability of percentage of fecal unconjugated primary bile acids over time in fecal samples stored in −80°C. Samples stored for 1.5–4 years (median 2.5).</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12365994/bin/JVIM-39-e70206-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">JVIM-39-e70206-s002.docx</a><sup> (41.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Data S4:</strong> Long‐term follow up data of CE dogs treated with BAS.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12365994/bin/JVIM-39-e70206-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JVIM-39-e70206-s001.docx</a><sup> (13.2KB, docx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Veterinary Internal Medicine are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/jvim.70206"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/JVIM-39-e70206.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (424.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365994/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365994/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365994%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365994/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365994/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365994/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40833185/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365994/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40833185/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365994/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365994/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lsWZtid57wA1x07fRrVQzbZTp3cg4pFORyMLAI3wYdEg1cxOzD1abpyvoudGjQ3U">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
